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 PREFACE
The Internationai Joint Commission Great Lakes Science Advisory Board's
Task Force on the HeaTth Effects of Non-NTA Detergent Budeers presents its
finaT report.
The foTTowing budeers were studied and Chapters contributed by
individuai members of the Task Force, viz:
Carbonates;
CarboxymethyToxsuccinate (CMOS);
CarboxymethyTtartronate (Budeer "M”);
Citrates;
Phosphates;
SoTubTe SiTicates; and
ATuminosiTicates (Type A Sodium ZeoTite).
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SUMMARY
lﬂEEQQEEEiQQ
Under the 1972 Great Lakes Water Quality Agreement between Canada and the
United States, measures were taken to reduce the input of phosphorus to the
lakes from municipal sewage; phosphate containing household detergents having
been determined as major contributors. The consequent restrictions in the use
of phosphate in detergents have led to an increase in the use of alternative
detergent builders.
Three task forces were established by the Science Advisory Board (formerly
the Research Advisory Board) to review the health effects of these materials
resulting from man's exposure to the aquatic environment and to review the
ecological safety of alternative builders in current or projected use, viz:
0 Task Force on the Health Implications of NTA (nitrilotriacetic acid),
final report published, May, 1977;
0 Task Force on the Ecological Effects of Non-Phosphate Detergent
Builders, a report on NTA, December, 1978, studies of other builders
are still underway; and
0 Task Force on the Health Effects of Non-NTA Detergent Builders, final
report due in 1980.
Emeelzsitucﬂsd
The latter task force studied the following builders:
1. Carbonates
Soluble Silicates
Ty
pe
A
Ze
ol
it
e
(a
sy
nt
he
ti
c
al
um
in
os
il
ic
at
e)
2.
Car
box
yme
thy
lox
ysu
cci
nat
e
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- L
eve
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rot
her
s)
3.
Car
box
yme
thy
lta
rtr
ona
te
(fo
rme
rly
Bui
lde
r "
M"
- M
ons
ant
o C
o.)
4. Citrates
5. Phosphates
6.
7.
  
 The task force was aided in its quest by information provided under the
auspices of the Canadian and U.S. Soap and Detergent Associations,
respectively. Conclusions were based on present knowledge using current
state-of-the-art techniques in toxicological assessment.
Results and Conclusions
 
A summary is provided below of the findings of the Task Force on the
Health Effects of Non—NTA Detergent Builders as listed above.
1. Carbonates. The range of available toxicity studies in experimental
animals is limited. No mutagenic or teratogenic effects have been
reported. Carbonates occur naturally in water. They have a long history
of use as food additives and as such are classified as Generally
Recognized as Safe (GRAS). Carbonates have also been used at high levels
for the treatment of peptic ulcers. It is concluded that the use of
carbonates as detergent builders poses no human health hazard through
their contribution of carbonate to drinking water.
2. Carboxymethyloxysuccinate — CMOS (Lever Brothers). The toxicological
studies reported by Lever Brothers indicate that CMOS is essentially
non—toxic and produces no demonstrable effects of carcinogenicity,
mutagenicity or teratogenicity. It was concluded that, based on the Lever
Brothers report, CMOS poses no health hazard to man from chronic ingestion
from drinking water.
3. Carboxymethyltartronate CMT - Formerly Builder "M" (Monsanto Co.). This
material is not presently commercially available but may still be a
candidate builder. Toxicological studies have been reported by the
Monsanto Company.
The task force concluded that, from its chemical structure and properties
and the reported results of acute and subchronic toxicity tests, CMT would
not be expected to pose an undue health hazard to man. The types of tests
5.
performed on CMT have been appropriate for safety evaluation but the lack
of primary data in most areas, including chronic toxicity data and
reproductive studies in addition to the unknown genetic risk to man,
precludes full assessment of the potential health affects of this
substance following prolonged exposure by man to the chemical in drinking
water.
Citrates. Citric acid and its potassium, sodium and calcium salts are
GRAS substances, occurring both naturally and as additives in many foods
and are also normal human metabolites of carbohydrates. Acute, subchronic
and chronic toxicity tests of citrates show no oral or dermal effects or
eye irritation. No mutagenic or teratogenic effects have been reported
nor is potential carcinogenicity suspected of citrates.
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 detergent builder.
In the body, sodium silicate is metabolized to and
excreted as silicic acid, which is relatively abundant in nature and a
normal constituent of human urine.
Acute, subchronic and chronic toxicity tests indicate that sodium silicate
is essentially non-toxic.
No mutagenic effects were observed and no data
are available on either teratogenic or carcinogenic effects.
The Select Committee of the Federation of American Societies for
Experimental Biology (FASEB) concluded in a 1979 study that sodium
silicates and certain other silicates used as food ingredients do not
present a public health hazard under current usage.
This conclusion
supported the results of an earlier (1974) FAG/WHO toxicological
evaluation of silica and certain silicates used as food additives, which
established no limit for the acceptable daily intake of the silicates
studied except for magnesium silicate and talc.
The task force concurs
with these conclusions
in regard to the human
health safety of soluble
silicates used as detergent builders and their potential contribution of
silicon to drinking water.
Type A Zeolite (a synthetic aluminosilicate). Aluminosilicates are widely
 
utilized in the food industry and in treating drinking water, not posing a
human health hazard under current conditions of use. Cubic Type A
Zeolite, with a Na:Si:A1 ratio of 1:1:1 is thermodynamically less stable
than food grade aluminosilicate, with its corresponding ratio of 1:1:13,
rapidly forming soluble aluminates and silicates in aqueous suspensions at
a pH <8;
hence rarely being found
in the environment.
Type A Zeolite is essentially non-toxic in chronic toxicity tests on
animals, the behaviour being representative of the silicates formed on
hydrolysis
rather
than
that
of
the
aluminates.
No
carcinogenic
or
teratogenic effects result from Type A Zeolite exposure and it is unlikely
to produce mutagenic behaviour.
 Considering the normal exposure of man to natural silicon compounds
without evident health hazards and the miniscule increase in silicon
levels in drinking water resulting from the proposed use of Type A Zeolite
in detergents, the task force concludes that use of this zeolite in
detergents is not anticipated to lead to adverse human health effects.
N
*9.
$5. 7
5" '.
11,
33
A
r
  
  
  
  
1. INTRODUCTION
During the last two decades it has become clear that phosphorus is one of
the principal nutrients contributing to the process of eutrophication observed
in many inland waters, including The Great Lakes.
While phosphorus loadings
to the lakes have many origins, the contribution through domestic wastewater
was identified as one of the principal sources. In recognition of this, the
1972 Great Lakes Water Quality Agreement between Canada and the United States
called for the development and implementation of waste treatment programs and
other measures to reduce inputs of phosphorus to the lakes from municipal
sewage. Phosphate-containing detergents were identified as one of the main
sources of controllable wastewater phosphorus. It was thought that
restrictions on this detergent use of phosphate would immediately reduce
phosphorus loadings to the lakes in the absence of the wastewater treatment
technology and treatment plants with the capability to reduce the phosphorus
from all sources in municipal wastewater to an acceptable effluent level. The
restrictions which were therefore imposed on the use of phosphate in
detergents have resulted in the increased use of alternative detergent builder
materials and their consequent release to the aqueous environment.
The International Joint Commission Science Advisory Board created three
task forces to investigate the state of knowledge of the health and ecological
effects of the builder materials being used or that were anticipated to be
used as a result of the restriction on the use of the phosphate materials.
A Task Force on the HEALTH IMPLICATIONS OF NTA AS A DETERGENT BUILDER has
completed its study and reported its findings to the IJC in July 1977.
(Reference: "A Report to The Great Lakes Research Advisory Board of the
International Joint Commission on the Health Implications of NTA May 1977".)
In response to this report, the Science Advisory Board concluded, "the Board's
conc
lusi
on t
hat
on t
he b
asis
of h
ealt
h ha
zard
ther
e is
no r
easo
nabl
e ca
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for
rest
rict
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use
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n".
(Ref
eren
ce:
Annu
al R
epor
t of
the
Rese
arch
Advi
sory
Board, IJC, July l977).
 
 A second Task Force on the ECOLOGICAL EFFECTS OF NON-PHOSPHATE DETERGENT
BUILDERS has completed its study of NTA and recommended, "that NTA should not
be prohibited from use as a detergent builder." (Reference: Ecological
Effects of Non-Phosphate Detergent Builders: Final Report on NTA, IJC
December 1978.) This second task force has continued its study of materials
other than NTA.
This third Task Force on the HEALTH EFFECTS OF NON—NTA DETERGENT BUILDERS
was established to consider the health effects of detergent builder materials
other than NTA that are currently in use or are likely to come into use. This
third task force consisted of scientists selected from areas that address the
health effects of such materials. In addition, to facilitate awareness of
unpublished data and ongoing research being conducted by industry and
governments, liaison members were solicited from the Soap and Detergent
Associations of Canada and the United States and appropriate federal agencies
from the two countries. Adjunct memberswith specific areas of expertise were
added to assist the task force in its review. Appendix B lists the task force
and liaison members and Appendix A lists the terms of reference of the task
force.
Seven materials were identified for examination by the task force: the
organic polycarboxylate builders other than NTA — citrate, carboxymethyloxy—
succinate (CMOS), and carboxymethyltartronate (Builder M), and the inorganic
builders - carbonate, silicate, aluminosilicate (Type A Zeolite) and phosphate.
One procedure followed by the task force was to arrange industry and/or
company presentations on the current, known, information available on the
health effects of these materials. These were arranged either as meetings
with written summaries or as summaries provided only in written form. Task
force and adjunct members reviewed this information and discussed and queried
pertinent aspects. Another procedure was to undertake research of available
information through computer assisted reviews of the published literature and
through specially arranged conferences.
The findings of the Task Force on the Health Effects of Non-NTA Detergent
Builders are presented in the following chapters.
8
  
2.CARBONATES *
Introduction
The avaiiabTe information on the bioTogicaT effects of "carbonates" has
been summarized in the GRAS Monograph and in the $0003 (Seiect Committee on
GRAS Substances) Report. These reports were prepared for the U.S. FDA, as
part of its ongoing survey of the safety of GRAS (GeneraTTy Recognized as
Safe) food chemicais. The documents are availabTe from the NationaT TechnicaT
Information Service, U.S. Department of Commerce, VA 22151. The foTTowing
information has been abstracted from this document. It is considered to be
the most reTevant for evaTuating the possibTe heaith effects of carbonates to
man.
Environmentai Leveis
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d
to
surface water, 0.0093 mg/L (TabTe 2, (3)).
*Contributed by 5.1. Shibko
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TABLE 1
C03_ AND HC03- CO
NCENTRATIONS IN R
AW DRINKING WATER
SUPPLIES
 
Great Lakes
Eastern Coast
Mid-West
mg/L
mg/L
mg/L
HC03_
C03 HC03_
C03” HC03_
C0
3
 
Miiwau
kee, M
isc.
134
Newark
, N.J.
132 Richmond, VA.
95 Charlotte, N.C.
111
AtTanta, Ga.
23
Topeka, Kan.
O 322
41
Des Moines, Iowa
0 340
20
Kansas City, Mo.
0 198
15
Omaha, Ne
b.
0 2
§§
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.
Det
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O
O
O
O
O
I
—
l
I
—
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Avg.
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Avg.
25
Avg.
275
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=
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3
mg
/L
 Acute Toxicity
L050
(Dosage mg/kg
Substance
Animal
No.
Route
body weight)
Ref.
Potassium
carbonate
rats
unk.
oral
1870
(4)
Sodium
bicarbonate
rats
unk.
oral
4300
(a)
(5)
Sodium
bicarbonate
rats
unk.
oral
6000
(b)
(5)
Sodium
bicarbonate
rats
unk.
oral
5500
(c)
(5)
Sodium
bicarbonate
rats
unk.
oral
4850
(d)
(5)
Sodium
bicarbonate
rats
unk.
oral
5900
(e)
(5)
a in a 20% slurry
b in a 50% slurry
c dose volume 20 mL/kg
d dose volume 50 mL/kg
e dose volume 20 mL/kg + 30 mL water
Subchronic Toxicity and Metabolism
 
The available data in mammalian species
is extremely limited.
Calcium
carbonate
fed
to
rats
at
a dietary
level
of
3% for
4 months
resulted
in
suppression of growth.
The decrease
in growth may have
been due to an
imbalance in the Ca/POu ratio,
since no additional phosphate was
added to
the experimental
diets
(6).
C from Cl“ carbonates,
is readily incorporated
into the metabolic pool.
It is mainly excreted by respiration,
but some is
incorporated
into
liver
glycogen,
fats
and
proteins
(7).
Reproduction Studies
Swiss
white
mice
were
fed
diets
containing
0,
0.5,
1
and
1.9%
calcium
carbonate.
There was
a significant
decrease
in the
total
weight
of
the young
at
weaning
in
the
1.9%
group.
The
same
effect
was
observed
in
subsequent
litters.
Autopsy
of
the
offspring
at
21
days
of
age,
in
the
1.9%
group,
showed
pale
speckled
livers,
enlarged
heart
and
small
thymus
glands
(8).
12
 C
h
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and
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t
y
No data available.
Mutagenicity
The
genetic
activity
of
sodium
bicarbonate
and
potassium
carbonate
was
assessed
in
microbial
assays,
with
and
without
the
addition
of
mammalian
metabolic
enzymes.
The
indicator
organisms
used
for
the
tests
were
Saccharomyces
cerviseae,
strain
D4,
and
Salmonella
typhimurium,
strains
TA-1535,
TA-1537
and
TA-1538.
Sodium
bicarbonate
and
potassium
carbonate
were
not
mutagenic
either
directly
or
in
the
presence
of
organ
homogenates
in
any
of
the
in
vitro
systems
tested
(9).
Teratogenicity
The
following
studies
have
been carried
out
to
evaluate
the
possible
teratogenic
effects
of
sodium
carbonate
and
sodium
bicarbonate:
Sodium bicarbonate
Albino mice (CD—l outbred mice) were dosed on day 6-15 of gestation by
oral intubation at dose levels of 5.80, 27.0, 125.0, or 580.0 mg/kg.
Albino rats (Wistar derived stock) were dosed on day 6-15 of gestation by
oral intubation at dose levels of 3.40, 15.8, 73.3, or 340.0 mg/kg.
Sodium carbonate
Albino mice (CD-1 outbred mice) were dosed on day 6-15 of gestation by
oral intubation with dose levels of 3.40, 15.8, 73.4, or 340.0 mg/kg.
Albino rats (Wistar derived stock) were dosed on day 6-15 gestation by
oral intubation at dose levels of 2.45, 11.4, 52.9, or 240.0 mg/kg.
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 individuals, bicarbonate is readily metabolized and excreted through the lungs
as C02 or through the kidneys. Abnormal effects reported in experimental
animals fed calcium carbonate appear to be related to the excess calcium,
causing a mineral imbalance, rather than to carbonate or bicarbonate per se.
Conclusions
The available biological data indicate that the present—day human exposure
to carbonates and bicarbonates from food and other sources does not pose a
health hazard. No hazard is anticipated from the use of carbonates and
bicarbonates as detergent builders, through their contribution to the loads of
carbonates and bicarbonates in drinking water.
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 3. CARBOXYMETHYLOXYSUCCINATE (CMOS)*
Introduction
A potential detergent builder developed recently, it is empirically
isomeric with citric acid. The structure is shown in Figure 1. It should be
noted that the abbreviation "CMOS" stands for the tricarboxylic anion.
CHz-COONa CHz-COONa
IH—COONa OHC-COONa
9 CHz-COONa
CHz-COONa
Sodium CMOS** Sodium Citrate
FIGURE 1
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e c
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l m
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 water and the environment. The polarity and metabolic fate in the environment
precludes bioaccumulation or biomagnification in mammals. Environmental
levels will range from 0.015 to 0.18 mg CMOS/L in receiving streams depending
on whether secondary or primary sewage treatment is utilized. Based on the
metabolic fate of CMOS, levels in drinking water are unlikely to exceed 0.05
mg/L.
5292119112111
Lever Brothers have studied in some detail the acute toxicity of CMOS
salts in several animal species. The results of these tests are summarized in
Table 1. It is apparent that CMOS salts are not acutely toxic to mammals.
TABLE 1
ACUTE TOXICITY 0F SODIUM CMOS
Test Species Result Comments
(M&F)
Oral L050 Rat 2.4-3.5 g/kg LD50 NaCa CMOS (species in the
environment) = 29.5 g/kg
Skin irritation Rabbit Nonirritant Intact and abraded skin utilized
Eye irritation Rabbit Nonirritant Cornea, Iris and Conjunctiva studied
Acute Dermal Rabbit LDso>5.Qg/kg No lethality at 5.9 g/kg
Acute Inhalation Rat 6-hr LCso 3 No lethality at 8.25 g/m3
>8.25 g/m
Sensitization Guinea Nonsensitizing Intradermal injection
Pig
   
Detergent formulations containing sodium CMOS were tested for consumer
safety. Powdered formulations, similar to those available commercially, but
containing CMOS, were essentially non-toxic with an oral LC >5g/kg in
rats. They were noncorrosive in an esophageal corrosivity tgst, were only
mild-to-moderate irritants in an occluded rabbit skin test and were only
18
 slightly irritating to rabbit eyes. Human patch tests further confirmed the
safety of CMOS—containing detergents. Detergent formulations containing
sodium CMOS were both nonirritating and nonsensitizing.
Subchronic Toxicity and Metabolism
Subchronic studies in rats at doses of sodium CMOS up to 1.0 g/kg for 30
days and 4.5 g/kg for 10 days indicated minimal toxicity for this material.
In the ten day rat studies, marked diarrhea, decreased growth rate and
increased spleen weight were noted only at doses approaching the LDso
(2.6-4.5 g/kg). No changes in histopathology, hematology or urinalysis were
reported, but an increase in blood urea nitrogen and a decrease in serum
glob
ulin
was
obse
rved
in m
ale
rats
fed
1.0
g/kg
/day
for
30 d
ays.
The
conc
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pro
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 TABLE 2
MAMMALIAN ABSORPTION AND EXCRETION OF CMOS
Percent of Dose Excreted
No. of Urine Feces 0.1.
Species Subjects Dose 24 hr 24-72 hr 24 hr 24—72 hr Tract TotaT
  
Rat 3 25 mg; 12 uCi 71.2 2.3 26.9 1.9 —- 102.3
Monkey 3 487 mg; 232 uCi 2 2 9 53 30* 96
Man 3 500 mg 2 1 not assayed ——
        
*average recovery from the GI tracts of monkeys at necropsy 72 hr post dosing
(range 24-45%)
Chronic Studies
ATthough three separate chronic studies were carried out in rats, the
appropriateness of the maximum dose utiTized (300 mg/kg) and the materiaT
tested shoqu be examined. It is true thatno pathoiogicai Tesions were noted
in 6, 12 and 24 months, but is unusuai to carry out a chronic toxicity study
where no overt signs of toxicity were noted in the high dose animaTs. The
Tack of observed toxicity maysimpTy be an indication of the reTative
non-toxicity of CMOS, but such an hypothesis requires experimentai
verification. The use of NaCaCMOS in chronic toxicity studies woqu seem
appropriate. From the physicai chemicaT properties of CMOS it can be
caicuTated that man wiTT be exposed to the CaCMOS ion, not to the CMOS species.
No toxicity was noted in maie or femaTe rats fed diets containing 63, 250,
1000 or 4000 mg CMOS/kg diet for six months. In a 16 month study NaCaCMOS
(the probabTe environmental species) was fed at 1000 and 5000 mg/kg diet to
maTe and femaTe rats prior to and after mating, as weTT as to the progeny for
16 months. No treatment-reTated toxic response was noted. In the finaT
chronic toxicity test, maTe and femaTe rats were fed diets containing 22, 216
and 3600 mg CMOS/kg for one year and diets containing 25, 246 and 4100 mg
NaCaCMOS for another year. A smaTT decrease in ovary weight was noted, but no
morphoiogicai changes were noted in the tissue sections.
20
 When evaluated on the basis of growth rate, food consumption, survival,
gross observations, hematology and gross and microscopic observations of
tissue, it was concluded that levels of CMOS as high as 3600/4100 mg
NaaCMOS/NaCaCMOS/kg of diet caused no significant chronic adverse effects
in rats.
The effect of CMOS salts on reproduction in rats was studied in a three
generation study. No alterations in fertility, gestation, viability or
lactation indices were reported when Na3CMOS and NaCaCMOS were fed at
dietary levels of 63, 250, 1000 and 4000 mg/kg. In a second study, these
results were corroborated. Also in the latter study, no teratogenic effects
were reported in the Fla generation after feeding diets containing 3600 mg
NaaCMOS/kg of diet. The Company concludes that CMOS salts do not
adversely effect the reproductive ability, nor the embryonic and fetal
dev
elo
pme
nt
in
rats
.
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a c
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compounds
were
nonmutagenic.
In
the
host-mediated
assay
utilizing
§L
typhimurium
TA
1530
and
0-46,
as
well
as
Saccharomyces
cerevisiae
0—3,
no
mutagenicity
was
noted
after
dosing
mice
with
4,
40
or
400
mg/kg
body
weight/day.
No
chromosome
aberrations
were
noted
in
male
rats
fed
diets
containing
levels
of
NaCMOS
as
high
as
500
mg/kg
for
3
generations.
After
six
months
exposure
of
male
rats
to
dietary
levels
of
NaacMOS
or
NaCaCMOS
of
4000
mg/kg,
no
mutagenic
activity
was
noted
in
a
dominant
lethal
test.
‘
It
was
concluded
that
CMOS
did
not
pose
a
mutagenic
hazard
to
man.
The
negative
mutagenicity
data
also
support
the
negative
carcinogenicity
data
discussed previously.
Teratology
Extensive
teratology
experimentation,
using
several
protocols,
was
reported
by
Lever
Brothers.
The
teratological
potential
of
NaacMOS,
sodium
citrate,
distilled
water
and
Vitamin
A
were
compared
in
rats.
While
Vitamin
A
caused
a
significant
number
of
teratogenic
changes,
no
such
adverse
effects
were
seen
in
the
water
control,
CMOS
or
citrate
dosed
animals.
Doses
of
NaCMOS
up
to
300
mg/kg
were
given
between
days
6-15
of
gestation,
and
doses
of
NaCMOS
as
high
as
1000
mg/kg
were
administered
to
rats
between
days
1-7,
7-14,
14-21
and
1-21
of
gestation
(period
of
organogenesis).
No
mobilization
of
heavy
metals
by
CMOS
was
reported,
nor
was
any
potentiation
of
cadmium
toxicity
noted
in
the
hamster.
Summary
Lever
B
r
o
t
h
e
r
s
have
concluded,
on
the
basis
of
their
t
o
xi
c
o
l
o
g
i
c
a
l
e
xa
m
i
n
a
t
i
o
n
,
that
CMOS
poses
no
hazard
to
man
f
r
o
m
c
h
r
o
n
i
c
ingestion
f
r
o
m
d
r
i
n
k
i
n
g
water.
A
c
ut
e
t
o
xi
c
i
t
y
was
similar
to
o
t
h
e
r
b
ui
l
d
e
r
s
now
in
use.
Based
on
their
s
um
m
a
r
y
report,
and
the
p
r
i
m
a
r
y
data
a
va
i
l
a
b
l
e
this
c
o
n
c
l
us
i
o
n
is probably valid.
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 4. CARBOXYMETHYLTARTRONATE
(Builder ‘M’)*
Introduction
Monsanto has developed a new polycarboxylic acid detergent builder, called
carboxymethyltartronic acid (CMT). This builder has often been referred to as
Builder "M", and the structures of the major components are shown in Figure 1.
 
$00Na $00Na EOONa $00Na $00Na $00Na
H$-——O-——~—CH2 HC-——O—.———$H 2HC__.0 CH2
COONa OONa COONa
Sodium Carboxy- Sodium Ditartronate Sodium Diglycolate
methyltartronate (7%) (3%)
(NaCMT - 76%)
Figure 1
The builder is composed of all three chemicals shown in Figure 1. The term
CMT used in this report refers to the mixture used in detergents.
At present, this material is not commercially available, but given the
proper economic situation, the chemical properties of CMT as a builder might
pla
ce
it
in
a c
omp
eti
tiv
e
pos
iti
on
wit
h
oth
er
che
mic
als
.
For
thi
s r
eas
on,
a
discussion of the human health aspects of this builder seems in order.
Mon
san
to
Com
pan
y
has
inf
orm
ed
the
Tas
k
For
ce
tha
t
res
ear
ch
is
sti
ll
pro
cee
din
g
on
CMT
,
but
wit
h
a v
ery
low
pri
ori
ty.
The
onl
y
rep
ort
ava
ila
ble
on
CMT
was
pre
par
ed
by
Mon
san
to
(Bu
ild
er
“M”
,
Env
iro
nme
nta
l
and
Hum
an
Saf
ety
,
Mar
ch
197
8).
No
pri
mar
y
tox
ico
log
ica
l
dat
a
hav
e b
een
rev
iew
ed,
nor
hav
e
any
of
the
tes
t
res
ult
s
bee
n
pub
lis
hed
for
pee
r
rev
iew
.
Environmental Levels
It
ha
s
be
en
es
ti
ma
te
d
th
at
dr
in
ki
ng
wa
te
r
co
ul
d
co
nt
ai
n
le
ss
th
an
0.
02
mg
CM
T/
L
un
de
r
us
e
co
nd
it
io
ns
wh
er
e
al
l
de
te
rg
en
ts
co
nt
ai
ne
d
25
%
w/
w
CM
T.
Ba
se
d
* Contributed by G.C. Becking
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3
 on chemicaT properties and economic factors, CMT woqu never be used at this
TeveT.
Acute Toxicity
The oraT L050 for CMT in rats has been reported as 2-3 g/kg whiTe the
dermaT MLD in rabbits was found to be greater than 8 g/kg. CMT was reported
as non-irritating to rabbit eyes and skin.
No evidence of primary irritation,
fatiguing or sensitization was found in 200 human subjects.
Subchronic Toxicity and Metaboiism
 
Monsanto has carried out 90—day feeding studies in dogs and rats.
The rat
appeared to be more sensitive to CMT than dogs.
No adverse effects were
reported in dogs fed diets containing 10,000 mg CMT/kg for 90 days, whereas a
no-effect TeveT in rats of 3000 mg/kg diet was reported. The onTy adverse
effect in rats fed CMT at 10,000 mg/kg diet was an increased urinary excretion
of caTcium. In a 30-day study, rats were fed diets containing 3000 mg CMT/kg
diet and no enhancement of methyT mercury toxicity by CMT was noted.
In aTT
subchronic studies, the indicators of toxicity were mortaTity, gross and
histopathoiogy, hematoTogy and urinaTysis.
MetaboTism data on CMT are minimaT, based onTy on singTe doses of
C-TabeTTed CMT administered to rats.
In such experiments,
90 percent of
the dose was excreted in 48 hours; 58 percent in the feces and 32 percent in
the
urine.
It
is
stiTT
not
certain
whether
the
excreted
materiai
is unchanged
CMT or various metaboTites.
Chronic Toxicity and Carcinogenicity
The
chronic
toxicity
and
carcinogenicity
tests
have
not
been
reported
in
finaT
form.
A
2-year
rat
study
and
an
18-month
mouse
study
at
NaCMT
dietary
TeveTs
between
1
and
10
g/kg
were
to
be
completed
in
1979.
A
2-year
study
in
rats,
where
drinking
water
contained
1.7g/L
of
NaCaCMT,
was
aTso
due
to
be
compieted
in
1979.
The
onTy
information
received
to
date
indicates
that
no
compound-reiated,
in—Tife
toxic
signs
were
noted
in
these
chronic
studies.
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Mutagenicity
The sodium and calcium salts of CMT have been tested for potential
mutagenicity in five strains of Salmonella typhimurium and Saccharomyces
cerevisiae D-3 with and without metabolic activation.
Even when 5 percent
solutions of NaCMT were studied, results were negative.
Dominant lethal tests in mice fed diets containing 5 g NaCMT/kg or
presented drinking water containing 1.7 mg CaCMT/L were negative. Also, after
8 weeks of dosing, no chromosome aberrations were found in bone marrow cells.
At a level of 1.7 g NaCaCMT/L in drinking water, two reciprocal
translocations were noted in 400 F1 male mice. Negative results were
obtained at 0.17 g NaCaCMT/L. The significance of these results is as yet
unknown.
Teratogenicity
The teratogenic potential of CMT was studied in rats and rabbits, using
fetal mortality, internal, external or skeletal alterations as indicators of
teratogenicity. Doses of 100-1000 mg NaCMT/kg were given orally to rats
between days 6-18 of gestation. No fetacidal or teratogenic effects were
noted. Similarly, no fetacidal or teratogenic effects were reported in
rabbits given oral doses of l00-300 mg/kg between days 6—18 of gestation.
In
the
rat
,
an
ora
l
dos
e o
f 1
00
mg/
kg
of
NaC
MT
did
not
alt
er
the
cla
ssi
cal
toxicity and teratogenic effects of methyl mercury.
Mon
san
to
Com
pan
y h
as
rep
ort
ed
tha
t m
ult
ige
ner
ati
on
rep
rod
uct
ive
stu
die
s
are in progress. No experimental results are available.
Summary
Fr
om
it
s
ch
em
ic
al
st
ru
ct
ur
e
an
d
pr
op
er
ti
es
,
an
d
th
e
re
su
lt
s
of
ac
ut
e
an
d
su
bc
hr
on
ic
to
xi
ci
ty
te
st
s,
on
e
wo
ul
d
not
ex
pe
ct
CM
T
to
po
se
an
und
ue
he
al
th
ha
za
rd
to
man
.
Th
e
ty
pe
s
of
te
st
s
ca
rr
ie
d
out
on
CM
T
ha
ve
bee
n
ap
pr
op
ri
at
e
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 for safety evaiuation but, given the lack of primary data in most areas, the
lack of chronic toxicity data and reproductive studies, as weH
as the unknown
genetic risk to man one cannot assess quy the potentia] heaith effects of
CMT after continua] exposure to this chemicai in drinking water.
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5.CHRATES*
Lntngdustigu
Thi
s
rep
ort
con
cer
ns
the
hea
lth
asp
ect
s
of
usi
ng
cit
ric
aci
d
and
its
sal
ts
as
bu
il
de
rs
in
ho
us
eh
ol
d
de
te
rg
en
ts
.
Th
e
mo
st
ex
te
ns
iv
e
use
s
fo
r
ci
tr
at
es
are
in
the
fo
od
and
ph
ar
ma
ce
ut
ic
al
in
du
st
ri
es
.
Ci
tr
at
es
ef
fe
ct
iv
el
y
ch
el
at
e
mo
st
di
va
le
nt
an
d
tr
iv
al
en
t
io
ns
(1
),
th
us
ma
ki
ng
ef
fe
ct
iv
e
de
te
rg
en
t
bu
il
de
rs
.
Ot
he
r
in
du
st
ri
al
use
s
in
cl
ud
e
me
ta
l
cl
ea
ni
ng
,
el
ec
tr
ol
yt
ic
po
li
sh
in
g
and
pl
at
in
g,
dy
ei
ng
,
wa
te
r
tr
ea
tm
en
t
an
d
ot
he
r
mi
sc
el
la
ne
ou
s
in
du
st
ri
al
pr
oc
es
se
s.
Ci
tr
at
es
(p
ar
ti
cu
la
rl
y
so
di
um
an
d
po
ta
ss
iu
m)
ar
e
ub
iq
ui
to
us
in
na
tu
re
,
ap
pe
ar
in
g
in
sm
al
l
am
ou
nt
s
in
mo
st
or
ga
ni
sm
s.
Ci
tr
at
e
is
a
no
rm
al
me
ta
bo
li
te
in
mo
st
li
fe
fo
rm
s
du
ri
ng
th
e
me
ta
bo
li
sm
of
ca
rb
oh
yd
ra
te
.
Environmental Levels
 
In
ge
ne
ra
l,
am
bi
en
t
ci
tr
at
e
le
ve
ls
in
th
e
aq
ua
ti
c
en
vi
ro
nm
en
t
ra
ng
e
be
tw
ee
n
0.
02
5
—
0.
14
5
mg
/L
,
wh
il
e
va
lu
es
as
hi
gh
as
8.
7
mg
/L
ha
ve
be
en
re
po
rt
ed
(2
).
Th
e
me
di
an
ci
tr
at
e
co
nc
en
tr
at
io
n
in
se
wa
ge
ef
fl
ue
nt
ha
s
be
en
fo
un
d
to
be
0.
2
mg
/L
.
Ci
tr
at
e
le
ve
ls
as
hi
gh
as
10
mg
/L
ar
e
ra
pi
dl
y
de
gr
ad
ed
to normal ambient levels (2).
L
o
n
g
-
t
e
r
m
hu
ma
n
ex
po
su
re
to
ci
tr
at
e
re
su
lt
in
g
fr
om
de
te
rg
en
t
us
e
wo
ul
d
be
p
r
i
m
a
r
i
l
y
o
r
a
l
,
t
h
r
o
u
g
h
i
n
g
e
s
t
i
o
n
of
d
r
i
n
k
i
n
g
wa
te
r.
0n
t
h
e
a
ve
r
a
g
e
,
d
r
i
n
k
i
n
g
w
a
t
e
r
c
o
n
t
a
i
n
s
0
.
0
0
2
-
0
.
0
0
5
m
g
c
i
t
r
a
t
e
/
L
a
n
d
t
h
i
s
w
o
u
l
d
i
n
c
r
e
a
s
e
t
o
0
.
0
0
8
5
m
g
/
L
if
al
l
d
e
t
e
r
g
e
n
t
s
w
e
r
e
b
u
i
l
t
w
i
t
h
2
5
%
c
i
t
r
a
t
e
(
2
)
.
If
t
h
i
s
o
c
c
u
r
r
e
d
w
i
t
h
o
u
t
d
e
g
r
a
d
a
t
i
o
n
,
m
a
n
w
o
u
l
d
c
o
n
s
u
m
e
0
.
0
2
m
g
c
i
t
r
a
t
e
/
d
a
y
f
r
o
m
h
i
s
d
r
i
n
k
i
n
g
wa
t
e
r
,
c
o
m
p
a
r
e
d
to
4
.
5
g
f
r
o
m
f
o
o
d
s
o
u
r
c
e
s
(3
).
*
Co
nt
ri
bu
te
d
by
G.
C.
Be
ck
in
g
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Acute Toxicity
A succinct summary of the acute toxicity of citrates is presented in a
report to the Food and Drug Administration (3). The era] L050 of sodium
citrate in mice was 7.1 g/kg. A11 mice receiving 4.8 g citrate/kg survived.
Another study indicated the ora1 LDso for citric acid in mice was 5 g/kg
and in rats as 12 g/kg. The signs of acute toxicity from citric acid in mice
and rats are those of organic acidosis and ca1cium deficiency.
Acute oraT toxicity studies of citric acid in man have not been reported,
but daiTy doses of potassium citrate as high as 10 9 have been used to render
urine Tess acid and as a mde diuretic (4).
Subchronic Toxicity
Rats administered citric acid in the diet (0.6 g/kg body weight) for 90
days exhibited no significant changes in body weight gain, bTood parameters,
histopathoTogy or reproduction (5). No behaviouraT, biochemica] or histo-
pathoTogicaT abnormaiities were produced in dogs fed citric acid, 1.38 g/kg,
for 112-120 days (4). '
It has been reported that citric acid fed to rats at a TeveT of 4.67 g/kg
body weight for 6 weeks produced a siight thymus atrophy and microscopic
spTenic foTTicTes (3).
Chronic Toxicity
Horn, gt_al., (6) fed citric acid to rats at TeveTs of 1.2 and 2.0 g/kg
body weight for 2 years. SurvivaT rates were not affected, but treated
animaTs grew more siowTy than controTs. After 2 years, organ weights were not
affected and no histopathoTogicaT changes were seen in thyroid, Tung, heart,
Tiver, spTeen, kidney, adrenaT, stomach, smaTT and Targe intestine, pancreas,
bone marrow or testicuTar tissue.
28
  
Rats
fed
diets
containing
1.2%
citric
acid
(daily
intake
0.8
g/kg)
showed
no harmful effects with respect to growth in 2 successive generations over a
90 week period.
No reproductive effects were noted, nor were significant
changes noted in hematology or histopathology (4).
Carcinogenicity
No carcinogenicity bioassay has been carried out on citric acid or its
salts. If citrate was carcinogenic to rats, one would have expected
significant histopathological changes in the chronic studies since such high
doses were utilized (4,6).
Mutagenicity
Citric acid, potassium and sodium citrate have been studied in a variety
of systems, both microbial and mammalian, with and without metabolic
activation. Microbial tests in Salmonella typhimurium (strains TA-1535, 1537
and 1538) and Saccharomyces cerevisiae, Du were negative for sodium and
  
potassium citrate.
Ci
tr
ic
ac
id
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s
fo
un
d
to
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no
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at
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,
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.
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Ci
tr
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ve
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al
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ra
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Si
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y,
at
0.6
mg
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L
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me
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ci
tr
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d
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not
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e
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ic
an
t
ch
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so
me
ab
er
-
ra
ti
on
s
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hu
ma
n
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br
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lu
ng
ce
ll
s
(W
I—
38
).
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/d
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r
5
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(3
).
Teratogenicity
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d
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im
al
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Summary
No evidence exists to indicate man's present daily intake of approximately
4.5 g of citrate poses a health hazard. Even if citrates were used at the
level of 25% in all detergents (highly unlikely), man's daily intake would
increase by less than 0.001% (0.4 mg/day). The World Health Organization (4)
indicated that an acceptable daily intake for citrates was "not limited". The
use of citrates in detergents poses no hazard to man.
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 6.PHOSPHATES*
LQECQQQEELOQ '
Phosphorus
is
an
element
essential
to
all
forms
of
life,
both
animal
and
plant.
Phosphorus
is
present
in water
as
orthophosphate,
and
in
soils
as
soluble orthophosphate and the insoluble apatite form.
Enough C02 is
present
in soil
water,
in equilibrium with the 602 in the air, to create
slightly acidic conditions, and thus permit continuing solubilization of the
apatite to the orthophosphate form that can be utilized by organisms (1).
Many other chemical forms of phosphorus anion exist; the relevant ones are
discussed below.
Phosphate-transfer reactions are vital to energy transfer and to the
metabolism of lipid, protein and carbohydrate. Phosphate is also an essential
part of the nucleic acid structure. Phosphorus is a major component of the
body, predominantly in the bones and teeth. The blood serum levels of
phosphorus in adults are usually in the 2.5-4.5mg/100mL range (1, 2, 3).
Phosphates have many important uses in industry and agriculture. Salts of
various forms of phosphate have been used extensively in detergents and
cleaning agents for many years. In detergents the condensed and polymeric
phosphate salts function as detergency builders while the salts of
orthophosphate provide alkalinity and emulsifying action (4). Approximately
95% of the phosphate used as detergent builder is sodium tripolyphosphate,
NasP301o, and most of the rest is tetrapotassium pyrophosphate, K9P207,
and tetrasodium pyrophosphate, NawP207 (5). Trisodium orthophosphate, NaaPOu,
has been used in heavy duty cleaning compounds or, in the dodecahydrate form,
is sold as such for that purpose (4).
There have been three general reviews relating to the safety of phosphates
to humans. A 1978 review (5) by the FMC Corporation, Monsanto, Olin and
* Contributed by R.D. O'Brien
  
 Procter & Gamble deals specifically with detergent phosphates, their
chemistry, industrial production methods and amounts and levels achieved in
water and sewage. The Food and Drug Administration reviewed in 1975 (3) the
health effects of phosphates in foods. The National Academy of Sciences
surveyed (6) in 1972 the extent of use of phosphate and other food chemicals
"generally recognized as safe.”
Levels
Since no known organisms can synthesize the phosphate anion, it has to be
absorbed through the food supply. Animal and cereal products are quite high
in phosphorus. For example, in approximate figures, cheddar cheese has 524
mg/lOOg, oatmeal 395mg/100g, eggs 224mg/1009, lean beef 240mg/100g. Plant
products have considerably less--lettuce 28mg/1009, potatoes 56mg/100g,
oranges 21mg/1009 (2).
It has been estimated that the total food supplies in the United Kingdom
provide about 1500mg of phosphorus per person per day (7). The 1972 NAS study
(6) estimated the average U.S. intake of phosphorus was 300mg per day, with
one third as calcium phosphates. The Food and Nutrition Board of the National
Research Council (USA) recommends a dietary allowance of 800mg of phosphorus
per day.
We now consider phosphorus intake from water. The total phosphorus
content in waters can be divided into that which is available and that which
is unavailable for biological assimilation. Part of the phosphorus associated
with any soil particle may be chemically or physically bound to the particle
and therefore unavailable. Based on river mouth data, the total phosphorus
load in the Great Lakes (presumably in the absence of detergent contribution)
consists of a soluble fraction and a particulate fraction. The soluble
fraction is essentially all readily available, but only a portion of the
particulate fraction is available.
The average contribution of household cleaners to the total phosphorus
load in domestic sewage was about 53% in 1969 and had been reduced to 38% by
32
#4.
 1976
(5).
Other
major
contributors
of
phosphorus
to
receiving
waters
in
addition
to
households
are
the
non-point
sources
which
include
agricultural,
forest
and
urban
runoff
and
atmospheric
sources.
The
phosphorus
contribution
from
detergents
flowing
into
the
Great
Lakes
is
10%
of
the
total
phosphorus
load to the Lakes.
Another
calculation,
by
the
detergent
manufacturers
(5),
was
based
on
a
"worst-case scenario”
in which there was no phosphorus removal
at municipal
sewage treatment plants, and only a hundred-fold dilution of the phosphorus
prior to discharge into receiving waters; the calculation also assumed that
phosphates made up 20% of detergents, which is no longer the case.
This
calculation showed 0.023mg of detergent phosphorus per litre as the averaged
value of phosphorus contribution to surface waters; local concentration could
of course vary substantially.
If the above calculations are correct, an individual drinking two litres
of water a day would take in 0.046mg of available phosphorus from detergent,
and about half as much from other sources. Another more specific calculation
from the same source computed in the case of Lake Erie is an intake of 0.008mg
per day derived from detergent. Either amount is small compared with the
300mg of phosphorus estimated above as the intake in the U.S.A. from food
sources.
Acute Toxicity
The detergent phosphates are categorized as having slight to moderate
acute toxicity (8). Massive ingestion of phosphoric acid and its salts
results in acidosis and hypocalcemia. Oral doses to produce death are very
larg
e, e
.g.
the
LDso
(the
dose
leth
al t
o 50
% of
the
anim
als)
of m
onob
asic
sodi
um p
hosp
hate
for
the
guin
ea p
ig i
s ov
er 4
49mg
of p
hosp
horu
s pe
r kg
of b
ody
wei
ght
(3).
The
acu
te
oral
LDso
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pen
tas
odi
um
tri
pol
yph
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hat
e i
n m
ice
is
811
mg
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pho
sph
oru
s p
er
kg
of
bod
y w
eig
ht
(2).
The
acu
te
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rat
s o
f s
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9/k
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kg
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not
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they are expected to be more toxic than the corresponding sodium salts due to
the inherently greater toxicity of potassium (8). The types of detergents
that contain phosphate builders, i.e. laundry detergents, automatic dishwasher
detergents, and hard surface cleaners and cleansers, are of low toxicity
having acute oral LDso's for rats of 3 to l3g/kg (10).
These levels for acute toxicity can be compared with the above data on
human intakes, recalculated on a body weight basis and assuming a body weight
of 70kg.
The phosphorus intake from food (using the U.S. value of 300mg per
day) would be 4mg/kg, or about one—hundredth of the guinea pig oral LDso.
‘
The intake from water, assuming a quantity of 0.075mg daily (which includes
potential detergent), would be 0.001mg/kg, which is less than the guinea pig
oral L050 by a factor of 450,000.
Weaver and Griffith (11) have shown that sodium tripolyphosphate, granular
detergents that contain 50—60% of this builder, and potassium pyrophosphate
are potent, prompt acting emetics when given orally to beagles.
As induction
of vomiting
is widely used as a first aid measure
in product
ingestion, these
authors
suggested that the emetic action of the phosphate builders provides
a
safety factor
in preventing the retention of detergent in the stomach.
Gosselin, gt al., (8) confirm that nausea and vomiting, and diarrhea as well,
are probable after ingestion of tripolyphosphate or pyrophosphates.
These
phosphates are thought to be hydrolyzed to orthophosphate before absorption.
If appreciable amounts of complex phosphate are absorbed,
there may be binding
of ionized serum calcium with a danger of hypocalcemic tetany.
One such
episode
apparently
occurred
in
a
case
involving
a
water
softener.
Trisodium
orthophosphate
or
TSP,
which
has
been
sold
in the
dodecahydrate
form
as
a
cleaning
agent,
forms
strongly
alkaline
solutions
in
water
and
is
reported
to
have
produced
injuries
on
ingestion
similar
to
those
caused
by
lye (8).
As
for
other
routes
of
entry,
there
is
an
example
of
acute
orthophosphate
toxicity
in
which
a
2
1/2
year
old
girl
developed
marked
hyperphosphatemia,
hypernatremia,
hypocalcemia
and
acidosis
after
two
pediatric
sodium
dihydrogen
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p
h
o
s
p
h
a
t
e
enemas
of
67.5mL
each
which
contained
3.79
of
phosphorus
(12).
Symptoms
started
to
appear
after
90
minutes
and
were
relieved
with
the
administration
of
calcium
gluconate.
0n
the
other
hand,
several
thousand
cases
of
accidental
ingestion
of
detergents
by
children
occur
annually
in
the
United
States
(13).
Many
of
the
products
involved
contain
phosphates,
and
follow-up
studies
confirm
that
complications
(other
than
nausea,
vomiting,
or
diarrhea)
rarely
occur
(14).
Topical
exposure
of
skin
and
eyes
to
phosphate
builders
usually
occurs
in
the
context
of
handling
or
using
the
detergent
products
that
contain
them.
Thus
most
reports
of
testing
involve
formulated
products.
However,
Nixon,
et
31.,
(15)
reported
that
50%
aqueous
sodium
tripolyphosphate
caused
negligible
irritation
to
intact
skin
of
rabbits,
guinea
pigs,
or
humans
in
four-hour
patch
test
exposures.
Under
the
same
test
conditions,
guinea
pig
and
rabbit
skin showed slight and moderate irritation, respectively, from a detergent
product
that
contained
50%
sodium
tripolyphosphate,
which
suggests
that
the
ingredients
other
than
the
phosphate
were more
likely the
source
of
irritation.
Human skin showed negligible irritation from the detergent.
A battery of skin and eye irritancy tests on animals or human subjects was
used on two detergents that contained 50% "condensed phosphate" (sodium
tripolyphosphate) to assess effects on skin and eyes (16). Another study (17)
involved similar products that also contained proteolytic enzymes. Both
studies showed mild irritant effects from the products. Predictive, repeated
application patch tests for skin sensitization involved 2055 human subjects in
the first series and 1478 in the second. There was no evidence of skin
sensitization, thus sodium tripolyphosphate apears to have no allergenic
propensities.
Subchronic Studies
Many studies have been done to investigate the short-term effects of
phosphates added to the diets of experimental animals. One of the signs
indicating a phOSphate overdose is the occurrence of metastatic calcium in the
kidney, stomach and aorta. Resorption of bone is also characteristic.
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Male
rats
fed
diets
containing
either
8%
metaphosphate
or
8%
sodium
orthophosphate
for
seven
months
or
until
death
showed
increased
urinary
excretion
of
inorganic
phosphorus,
enlarged
parathyroids
(2
to
8
times
that
of
controls),
and
calcium
deposits
in
the
tubules
of
the
outer
medulla
of
the
kidney
(18).
Calcification
occurs
in
the
area
of
the
Loop
of
Henle
and
the
terminal
part
of
the
proximal
tubule.
Hodge
carried
out
short-term
feeding
studies
with
rats
and
dogs
of
sodium
tripolyphosphate,
sodium
trimetaphosphate,
sodium
tetrametaphosphate,
and
sodium
hexametaphosphate
(19).
The
studies
were
designed
to
detect
and
assess
renal
damage
in
view
of
reported
harmful
effects
of
large
amounts
of
orthophosphate
on
the
kidney.
Weanling
rats
were
fed
diets
for
one
month
that
contained
0.2,
2.0,
or
10%
of
the
test
phosphate.
Control
rats
received
basal
diet
alone,
or
supplemented
with
10%
sodium
chloride
or
5%
sodium
orthophosphate.
Growth
retardation
was
seen
with
the
sodium
chloride
and
sodium
phosphate
control
rats
and
with
the
rats
receiving
10%
of
condensed
phosphate.
The
latter
rats
also
had
tubular
degeneration
and
necrosis
of
the
kidneys.
The
“no-effect"
level
of
the
condensed
phosphates
was
2%
in
all
cases.
Dogs
fed
0.lg/kg/day
of
the
condensed
phosphates
showed
no
effects.
Exposure
up
to
5
months
to
from
1
to
4g/kg/day
produced
renal
lesions
similar
to
those
seen
in
rats
at
10%
of
the
diet.
Ten
female
adult
mongrel
dogs
fed
diets
supplemented
with
potassium
phosphate
at
2.89
phosphorus/day
for
four
months
and
then
3.lg/day
for
six
months
showed
multiple
microscopic
areas
of
calcification
in
the
kidney
medulla,
decreased
urinary
calcium
excretion,
increased
urinary
phosphate
excretion,
increased
bone
resorption.
Eight
out
of
the
ten
dogs
developed
calcium
deposits
in
their
eye
lenses.
In
five
of
these
eight,
the
calcium
deposits
were
associated
with
changes
compatible
with
cataracts
(20).
If
the
levels
fed
to
dogs
in
the
above
e
xp
e
r
i
m
e
n
t
s
had
c
o
m
p
a
r
a
b
l
e
e
f
f
e
c
t
s
in
humans,
and
if
we
assume
the
dogs
weighed
7kg
and
the
humans
70kg,
then
the
daily
amounts
that
showed
undesirable
effects
were
equivalent
to
30,000mg
of
p
h
o
s
p
h
o
r
us
per
human,
wh
i
c
h
is
100
times
the
U.S.
intake
in
f
o
o
d
and
4
0
0
,
0
0
0
times
the
intake
in
water.
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t
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There are two relevant long—term feeding studies of condensed phosphates
use
d
in
det
erg
ent
s.
Hod
ge
fed
gro
ups
of
50
wea
nli
ng
mal
e a
nd
fem
ale
rat
s f
or
24
mon
ths
wit
h l
abo
rat
ory
cho
w d
iet
s c
ont
ain
ing
zero
, 0
.05,
0.5,
or
5%
sod
ium
tri
pol
yph
osp
hat
e
(19
).
The
add
ed
pho
sph
oru
s e
qui
val
ent
s w
ere
0.0
12,
0.1
25,
and
1.2
5%;
FAS
EB
est
ima
ted
tha
t t
he
hig
hes
t l
eve
l w
as
equ
iva
len
t
to
630
mg
of
ph
os
ph
or
us
ad
de
d
pe
r
kg
of
bo
dy
we
ig
ht
(3)
.
0n
th
e
ba
si
s
of
gr
ow
th
,
fo
od
con
sum
pti
on,
hem
ato
log
y,
uri
ne
ana
lys
is,
mor
tal
ity
,
org
an
wei
ght
s,
and
hi
st
op
at
ho
lo
gy
,
0.
05
and
0.
5%
so
di
um
tr
ip
ol
yp
ho
sp
ha
te
we
re
no
ef
fe
ct
lev
els
.
The
hig
h
lev
el
pro
duc
ed
gre
atl
y
inc
rea
sed
kid
ney
wei
ght
and
siz
e
in
mal
es,
ac
co
mp
an
ie
d
by
di
la
te
d
co
nv
ol
ut
ed
tu
bu
le
s,
in
te
rs
ti
ti
al
an
d
gl
om
er
ul
ar
fi
br
os
is
an
d
in
te
rt
ub
ul
ar
ca
lc
if
ic
at
io
n.
In
th
e
se
co
nd
st
ud
y,
tw
o
de
te
rg
en
ts
co
nt
ai
ni
ng
50
%
co
nd
en
se
d
ph
os
ph
at
e
(s
od
iu
m
tr
ip
ol
yp
ho
sp
ha
te
)
we
re
ad
de
d
to
la
bo
ra
to
ry
ch
ow
di
et
s
of
se
pa
ra
te
gr
ou
ps
of
40
ma
le
an
d
40
fe
ma
le
ra
ts
ea
ch
fo
r
tw
o
ye
ar
s
at
le
ve
ls
of
ph
os
ph
or
us
eq
ui
va
le
nt
to
0.
06
3%
(2
1)
.
Th
er
e
we
re
no
to
xi
c
ef
fe
ct
s
to
te
st
an
im
al
s
co
mp
ar
ed
wi
th
co
nt
ro
l
an
im
al
s
th
at
re
ce
iv
ed
th
e
ba
sa
l
di
et
.
If
th
e
h
i
g
h
e
s
t
n
o
—e
f
f
e
c
t
le
ve
l
in
th
es
e
tw
o
st
ud
ie
s,
63
mg
of
ph
os
ph
or
us
a
d
d
e
d
p
e
r
kg
o
f
b
o
d
y
w
e
i
g
h
t
,
is
c
o
m
p
a
r
e
d
w
i
t
h
t
h
e
"
w
o
r
s
t
-
c
a
s
e
“
h
um
a
n
i
n
t
a
k
e
of
d
e
t
e
r
g
e
n
t
—
d
e
r
i
v
e
d
p
h
o
s
p
h
o
r
u
s
in
d
r
i
n
k
i
n
g
w
a
t
e
r
of
0
.
0
4
6
m
g
p
h
o
s
p
h
o
r
u
s
(i
n
2
l
i
t
r
e
s
o
f
w
a
t
e
r
p
e
r
d
a
y
)
f
o
r
a
5
0
k
g
a
d
u
l
t
,
t
h
e
r
e
is
a
s
a
f
e
t
y
f
a
c
t
o
r
o
f
m
o
r
e
than 68,000.
Ca
rc
in
og
en
ic
it
y
an
d
Mu
ta
ge
ni
ci
ty
I
n
f
e
e
d
i
n
g
s
t
u
d
i
e
s
o
f
s
o
d
i
u
m
t
r
i
p
o
l
y
p
h
o
s
p
h
a
t
e
b
y
H
o
d
g
e
(
1
9
)
a
n
d
S
n
y
d
e
r
,
£
3
3
1
.
,
(
2
1
)
,
r
a
t
s
f
e
d
d
i
e
t
s
c
o
n
t
a
i
n
i
n
g
u
p
t
o
5
%
i
n
t
h
e
f
i
r
s
t
c
a
s
e
a
n
d
a
t
0
.
2
5
%
i
n
t
h
e
s
e
c
o
n
d
s
h
o
w
e
d
n
o
q
u
a
l
i
t
a
t
i
v
e
o
r
q
u
a
n
t
i
t
a
t
i
v
e
c
h
a
n
g
e
f
r
o
m
t
h
e
n
o
r
m
a
l
i
n
c
i
d
e
n
c
e
o
f
t
u
m
o
r
s
f
o
u
n
d
i
n
c
o
n
t
r
o
l
a
n
i
m
a
l
s
.
N
o
e
v
i
d
e
n
c
e
o
f
m
u
t
a
g
e
n
i
c
e
f
f
e
c
t
s
f
o
r
s
o
d
i
u
m
a
c
i
d
p
y
r
o
p
h
o
s
p
h
a
t
e
w
a
s
o
b
t
a
i
n
e
d
i
n
a
s
t
u
d
y
t
h
a
t
i
n
c
l
u
d
e
d
:
(
a
)
h
o
s
t
—
m
e
d
i
a
t
e
d
a
s
s
a
y
i
n
m
i
c
e
u
s
i
n
g
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(
 Salmonella
typhimurium
TA1530
and
mitotic
recombination
frequency
in
Saccharomyces
cerevisiae
D3;
(b)
in
11:39
mutagenic
assay
with
S;
typhimurium
strains
TA1535,
TA1536,
TA1537,
and
TA1538
in
the
presence
and
absence
of
metabolic
activation;
(c)
dominant
lethal
test
in
rats;
and
(d)
translocation
test in mice (3).
Teratogenicity
and
Reproductive
Effects
Sodium
tripolyphosphate
was
embryotoxic
but
not
teratogenic
in
avian
embryos
at
levels
up
to
32mg
of
phosphorus
per
kg
of
egg.
Sodium
tripolyphosphate
was
given
on
day
6
through
day
15
of
gestation
to
pregnant
mice
(up
to
60mg/kg
as
phosphorus),
pregnant
rats
(up
to
43mg/kg
as
phosphorus),
pregnant
hamsters
from
day
6
to
day
10
(up
to
36mg/kg
as
phosphorus),
and
pregnant
rabbits
from
day
6
through
day
18
(up
to
63
mg/kg
as
phosphorus).
No
effects
on
oval
implantation
or
maternal
or
fetal
survival
were
seen.
There
was
no
significant
increase
in
the
number
of
abnormalities
in soft or skeletal tissue (3).
Sodium
tripolyphosphate,
sodium
trimetaphosphate,
or
sodium
hexameta—
phosphate
had
no
effect
on
fertility
or
litter
size
nor
on
growth
or
survival
of
offspring
in
reproduction
studies
with
three
generations
of
rats
maintained
on
diets
containing
0.5%
of
condensed
phosphate
(19).
Conclusions
The
amount
of
phosphorus
contributed
by
detergents
to
human
intake
is
in
the
range
of
0.01
to
0.1mg
per
person
per
day,
and
is
therefore
exceptionally
small
compared
with
the
estimated
U.S.
food
intake
of
300mg
per
person
per
day.
Two
lines
of
evidence
suggest
that
detergent
phosphorus
derived
through
drinking
water
poses
no
health
hazard.
One
is
that,
in
comparison
with
the
above
human
intakes,
enormously
larger
amounts,
by
factors
of
several
hundred
thousand,
are
needed
to
produce
detectable
toxic
effects
(acute,
subchronic
or
chronic)
in
laboratory
animals
and
even
these
very
large
quantities
are
not
carcinogenic,
mutagenic,
or
teratogenic.
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 A
second
Iine
of
evidence
is
that
a
1975
review
(3)
for
the
Food
and
Drug
Administration of heaIth aspects of phosphates in foods showed that there was
no hazard from the 300mg of phosphorus taken in dain by humans in food;
indeed Such Iarge amounts are essentiaI for heaIth. These food intakes of
phosphorus are 6,000 times greater than water intakes, even under a
"worst-case" scenario. Phosphorus occurs in numerous forms; a1] the 23 forms
which have any significant representation in food and these incIude the forms
found in detergents and naturai water, were specificaIIy exonerated from any
hazards when used at current Ieveis. In December 1979 the Food and Drug
Administration proposed to affirm that such phosphates shouId be generaiiy
regarded as safe for addition to food. They exempted caicium hexameta-
phosphate and potassium ponmetaphosphate from this status because they were
not normaIIy used as food additives (22).
It is conciuded that phosphates used as detergent builders do not pose a
heaIth hazard through their contribution of phosphorus to drinking water.
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Introduction
Soluble silicates possess utility in a spectrum of applications including
food packaging, medical products, the treatment of drinking water and in high
phosphate, reduced phosphate and non-phosphate detergents.
The Select Committee of the Federation of American Societies for
Experimental Biology (FASEB, 1979) in a final evaluation for the U.S. Food and
Drug Administration of the health aspects of certain silicates as food
ingredients, concluded that sodium silicate, sodium aluminosilicate, calcium
aluminosilicate, calcium silicate, magnesium silicate, potassium silicate,
tricalcium silicate, silica aerogel and talc do not present a hazard to the
public under current use.
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con
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 (Na25i03). 0n the high silica side, commercial materials are non—stoichio-
metric. These are available as viscous solutions or as amorphous solids.
They are specified in terms of their weight ratios of Si02/Na20. Sodium
silicate, ranging from 2.0 to 2.5 SiOz/Na20, is most frequently used in
laundry detergents (Sturm, §t_al, 1978). The colloquial term "waterglass" is
now obsolete. It had been applied to viscous sodium silicate solutions of
about 3.3 SiOZ/Nazo as used for egg preserving (Wills, 1969).
As a detergent builder sodium silicate plays several roles, depending on
the function and composition of the detergent. For example, in phosphate-
built detergents, sodium silicate maintains soil particles in suspension and
is not a water softener. In contrast, in the carbonate/silicate builder
combination, the silicate buffers the solution at an alkaline pH where calcium
carbonate and magnesium hydroxide precipitate most effectively. The silicate
may sequester magnesium in carbonate and zeolite-built detergents.
Additionally, sodium silicate also deflocculates particulate soil, emulsifies
and saponifies greasy oil, absorbs liquid detergent ingredients, provides
crisp, free-flowing granules when spray dried and may also inhibit the
corrosion of metal in the washing machine (Sturm, §t_gl., 1978).
The levels of sodium silicate (Na20-25i0)2 in detergent based on various
use patterns are as follows (Sturm, gt_gl., 1978): (1) based on historical
use: 5%; (2) based on current use in reduced phosphate detergent: 10%; (3)
based on possible use in non-phosphate detergent: 20%. At concentrations
below 120 ppm, the only stable species in aqueous solution is monomeric and is
indistinguishable from naturally dissolved silica (Sturm, 33 al., 1978; Stumm,
1970).
Sodium silicate (at a concentration of 8 mg/L Si02) is added to
municipal and domestic water supplies to inhibit the corrosion of pipes, pumps
and tanks (Sturm, et al., 1978).
It is important to note that silica, silicic acid and the calcium,
magnesium and aluminum salts are ubiquitous in the environment and hence it
can be considered unlikely that man can avoid silicon exposure. At least 25%
44
 
  
of
the
earth's
crust
is
composed
of
silicon
in
the
form
of
silicon
dioxide
(sand
and
quartz)
and
the
salts
of
silicic
acid
(FASEB,
1979).
Silicon
is
found
in
all
natural
waters
(Krauskopf,
1967).
Ground
waters
contain
the
highest
concentrations
of
natural
silica.
Streams
and
rivers
contain
more
dissolved
silica
than
do
the
lakes
and
oceans.
For
example,
the
worldwide
concentration
of
silica
is
13.1
mg/L
while
that
of
the
Great
Lakes,
is
about
4
mg/L
(Sturm,
gt_al.,
1978).
Silica
levels
found
in
surface
waters
as
a result
of
detergent
use
(at
the
20%
level)
are of
the
order
of 0.064
mg/L
(6.4
mg/L
raw
sewage,
assuming
a
sewage
effluent
dilution
of
1:100)
(Sturm,
et
21., 1978).
A
survey
of the
mineral
content
of finished
water
in public
water
supplies
of 100 largest U.S.
cities in 1962 indicated that the median,
high and low
concentrations of silica were 7.1, 7.2 and 0.07 mg/L respectively (Durfor and
Becker, 1964).
Silicon is found in almost all terrestrial and aquatic organisms (Allison,
1968). In humans, the lungs and peribronchial lymph nodes have the highest
silica content, 14-2000 mg/lOOg and 27-5000 mg/lOOg respectively (King and
Belt, 1938). The silica content of these tissues increases with age and this
has been suggested to be due primarily to the continual inhalation of house
and street dust. In contrast there is a constant low concentration in other
organs and muscle that does not appear to vary with time (e.g., psoas muscle
and kidney concentrations are of the order of 23/100 mg/lOOg and 11-27 mg/lOOg
respectively) (King and Belt, 1938).
It should be additionally noted that foods contain naturally occurring
silicates. For example, levels of silicon (in the form of silicon dioxide) in
raw potatoes are about 10.1 mg/kg, in milk 2.1 mg/L and in beer 131 mg/L
(FASEB, 1979). Silica compounds used in food packaging include silicon
dioxides, sodium silicate and talc. The estimated possible intake of sodium
alum
inos
ilic
ate,
the
prin
cipa
l s
ilic
ate
food
addi
tive
, is
abou
t 0.
8 mg
/kg/
day
(FASEB, 1979). An additional human intake of silicon can arise from its
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 medicinal applications. For example, magnesium trisilicate is used as an
antacid in the treatment of hyperchlorhydria as found in peptic ulcers and
gastritis.
Although the function of silica in the body is not definitively known,
studies with chicks (Carlisle, 1972), rats (Levier, 1975; Schwarz and Milne,
1972) and monkeys (Levier, 1975) suggest that silica may play a role in the
calcification process in bones.
Toxicity
Since sodium silicate occurs naturally and has been used in home laundry
products in the United States and United Kingdom for approximately 120 and 150
years, respectively, few formal toxicity studies exist relating to sodium
silicate per se or in any soap and/or detergent formulation.
a. Acute Toxicity
The signs observed during eye, skin, esophageal and oral toxicity tests
included conjunctivitis, erythema, small blisters on skin, burns in oral and
alimentary canal, nausea and vomiting (International Tech. Inform. Inst.).
The acute oral LDso for sodium silicate (NaZO-nSiOZ x H20, n = 3.25, "water
glass") is 1100 mg/kg. The oral LDso for sodium silicate (silicic acid
disodium salt) is 1280 mg/kg in the rate (NIOSH, 1975; Philadelphia Quartz
00., 1961). The oral L050 for sodium silicate (3.0 SiOz/Nazo) in the rat is
1600 mg/kg. (NIOSH, 1975; Soap and Detergent Association, 1972).
In man, the estimated oral lethal doses are: >1Sg/kg for silica
(silicon dioxide) and magnesium trisilicate and between 0.5 and 5g/kg for
sodium silicate and in the latter case, may well be due to the compound's
alkalinity (Anon, 1964; FAD/WHO, 1974).
The intraperitoneal LDLo for sodium silicate (designated water glass)
in the guinea pig is 200 mg/kg (NIOSH, 1975). The minimal lethal i.v. dose of
sodium metasilicate (NaZSi03-9H20) for rabbits is 175 mg/kg. Doses between
110 and 172.5 mg/kg caused anemia. Sodium silicate at levels of 20.28-55.9%
was eliminated in the urine within 11-48 hours (Gajatto, 1951).
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 In
a
c
o
m
p
r
e
h
e
n
s
i
ve
recent
study
of
the
rate
and
extent
of
urinary
excretion
in
rats
after
oral
administration
of
magnesium
trisilicate,
food-grade
sodium
aluminosilicate
and
Zeolite
Type
A
administered
in
doses
of
0,
40,
200
or
1000
mg/kg,
and
sodium
silicate
in
doses
of
40
and
1000
mg/kg,
it
was
found
that
urinary
silicon
excretion
increased
rapidly
after
dosing
and
peak
excretion
rates
occurred
within
24
hours
in
all
test
groups
(Benke
and
Osborne,
1979).
Zeolite
A
had
the
most
rapid
urinary
excretion
rate
(half-life,
6-8
hr).
The
half-lives
of
magnesium
trisilicate,
sodium
silicate
and
food
grade
sodium
aluminosilicate
were
16-20
hr,
24
hr
and
38
hr,
respectively.
When
expressed
as a percentage
of
dose,
the
total
urinary
silicon
excreted
was
roughly
equal
for
magnesium
trisilicate,
sodium
silicate
and Zeolite A but considerably less for food grade sodium aluminosilicate*.
For
all
four
test
materials
urinary
silicon
excretion
increased
with
dose
level.
However, it should be noted that the magnitude of this increase (two
to
eightfold)
was
not
as
great
as
the
increase
in the
amount
dosed
(25-fold).
The observation that the percentage of silicon excreted decreased as the dose
was increased suggested that some process in the absorption or excretion was
becoming saturated. Similar findings were reported by King, gt_al., (1933)
who administered silicic acid to dogs and found that increasing the dose
caused a smaller fraction of the silicon to be excreted in urine. Comparable
data in humans is limited and appears to be available only for magnesium
trisilicate (Page, £3 31., 1941). When administered to volunteers at a dose
level of 35 mg/kg/day for 4 days and the urine is collected for 48 hrs after
the last dose, the total excess silicon recovered in urine averaged 5.2%. It
was noted by Benke and Osborn (1979) that although the data of Page, gt al.,
(1941) were not directly comparable to the single-dose data reported above in
the rat, it would appear that man absorbs less silicon from magnesium
trisilicate than does the rat. The hazards of ingested silicates are believed
to be generally limited to effects on the kidney and bladder (Emerick, gt_al.,
1963; Tracor-Jitco, 1973).
 
In man, except for non-specific irritation or corrosion of skin, cornea
and mucous membranes, no apparently toxic actions of sodium metasilicate are
recognized (Gleason, £3 31., 1968; Sax, 1968; Mills, 1969).
*Unlike Zeolite A, food grade sodium aluminosilicate is amorphous and differs
i . . . . Z
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b. Subchronic Toxicity
There may be species related susceptibility to renal damage from ingestion
of sodium silicate. When 15 rats of both sexes of the Charles River CD strain
were fed sodium silicate (no specified composition) at levels of 2.4 gm/kg/day
in a semi-synthetic diet for 4 weeks, the only clinical symptoms observed were
polydipsia, polyurea, and soft stools observed in a few animals. No compound-
related lesions were found and all clinical chemical tests were within normal
limits (Newberne and Wilson, 1970).
Pure-bred beagles of both sexes about 6 months of age were fed 2.4g/kg/day
of sodium silicate in a semi-synthetic diet for 4 weeks (equivalent to
0.89/kg/day of silicon dioxide as the end product). Gross cortical lesions of
the kidney were observed in 8/8 male dogs and in 7/8 female dogs. The lesions
appeared to be focal, subcapsular hemorrhages and on the cut surface the
lesions suggested cortical infarcts (Newberne and Wilson, 1970). Although the
nature of the lesion was the same in all cases, the severity varied from one
animal to another, and from one area to another within the kidney.
Hypertrophy of tubular epithelium, with or without degenerative changes,
inflammatory cell infiltration into the interstitium, and dilatation of some
and collapse of other tubular epithelium were all observed to varying degrees
within localized areas of the kidney. The general impression was one of
irritation of tubular epithelium followed by degenerative and regenerative
changes. These alterations were accompanied by inflammatory cell infiltration
into the interstitium. Although there was presence of extensive renal damage,
impairment of renal function was not detected by any of the clinical tests
conducted on serum or urine. It should be noted that magnesium trisilicate
administered to dogs at 1.8g/kg/day (also equivalent to 0.89/kg/day of silicon
dioxide) for 4 weeks produced the same lesions. It was speculated that both
sodium silicate and magnesium trisilicate were apparently absorbed from the
gut and damaged the kidney as they or their metabolic products were excreted
in the urine (Newberne and Wilson, 1970).
Settle and Sauer (1960) earlier reported that siliceous deposits formed in
the kidneys of guinea pigs given large dose of soluble silica orally or
intraperitoneally.
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 c. Chronic Toxicity and Carcinogenicity
There are no apparent reports in the literature of chronic testing or
carcinogenicity of sodium silicate in any form.
d. Mutagenicity
Sodium silicate was not mutagenic when tested with E; co i (Demerec, gt
al., 1951).
e. Teratogenicity
There are no existing teratogenicity data on sodium silicates.
f. Epidemiology
There have been no epidemiological studies related to sodium silicate
per
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 drinking water are not of primary significance in the pathogenesis of endemic
Balkan nephropathy as has been previously proposed (Markovic, 1972a,b;
Markovic and Arambasic, 1971).
All sodium silicate species, whether of natural or synthetic origin, lead
to the same monomeric silica in solution. Above the solubility limit for
monomeric silica, which is pH-dependent, oligomeric and finally polymeric
silica form. These processes are the same internally as elsewhere in nature
(Stumm, 1970; FASEB, 1979).
g. Metabolism
After ingestion, silicates have been reported to be decomposed in humans
to silicic acid which is excreted in concentrated form by the kidneys
(Markovic, 1972a,b). It has been postulated that when a silicate (e.g.,
magnesium trisilicate) is ingested or administered, part of the silica so
formed is precipitated as a gel and part remains in solution.
Silicic acid has been reported to be a normal constituent of human urine.
the amount excreted is in the range of 10-30 mg/day depending on the diet.
Ingested silicic acid rapidly penetrates the intestine and is distributed
throughout the extracellular fluid. Silicic acid has also been found in blood
at levels below 1 pg SiOz/cms. It has not been found to bind to protein or to
other large macromolecules (FAG/WHO, 1974).
Previous Evaluations and Summary
 
The FAO/WHO (1974) toxicological evaluation of silicon dioxide and certain
silicates in relation to food additives concluded that with the exception of
the reported damage to dog kidney by sodium silicate and magnesium
trisilicate, any silicate absorbed is excreted by the kidneys without evidence
of toxic cumulation in the body.
The available data on orally administered
silica and silicates appeared to substantiate the biological inertness of
these compounds.
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 As
noted
previously
in
this
report,
FASEB
(1979)
in
a
review
and
evaluation
of
the
health
aspects
of
certain
silicates
as
food
ingredients
for
the
U.S.
Food
and
Drug
Administration
concluded
that
sodium
silicate
(as
well
as
aluminum
calcium
silicate,
calcium
silicate,
magnesium
silicate,
potassium
silicate,
sodium
aluminosilicate,
tricalcium
silicate,
silica
aerogel
and
talc)
do
not
present
a
hazard
to
the
public
under
current
use.
The
"unpublished
GRAS
status”
of
sodium
silicate
for
direct
use
in
food
should
also be noted (SCOGS-61 report, FASEB, 1979).
The
U.S.
Public
Health
Service
has
also
stated
that
"the
use
of
small
amounts of sodium silicate added to drinking water would, as far as is known,
produce
no
ill-effects
upon
the
users
of
the
water"
(Vail,
1952).
Conclusion
It is concluded that the use of sodium silicate in detergents poses no
hazard to man.
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Introduction
Aluminosilicates
have
a
variety
of
uses,
including
the
food
industry.
Food grade aluminosilicate is approved for use in certain foods up to levels
of 2 percent.
Aluminosilicates,
aluminum compounds
and silicates are widely
used in the treatment of drinking water.
Recently,
the Federation of American Societies for Experimental Biology
completed a review and evaluation of the health aspects of certain silicates
as food ingredients for the United States Food and Drug Administration. (1)
The conclusion of the committee was that aluminum calcium silicate, calcium
silicate, magnesium silicate, potassium silicate, sodium silicate, sodium
aluminosilicate, tricalcium silicate and silica aerogel, do not present a
hazard to the public under current use. This conclusion was in agreement with
earlier decisions by the World Health Organization (WHO) and the Food and
Agriculture Organization(FAO), which established no limit for the acceptable
daily intake of these same silicates, with the exception of magnesium silicate.
This report concerns the health aspects of synthetic Type A Zeolite
(sodium aluminosilicate) utilized in household detergents. A review of the
chemical and toxicological data on this aluminosilicate (2,3,4) will be made
to a
scer
tain
whet
her
the
pote
ntia
l h
ealt
h ri
sk i
s ma
rked
ly d
iffe
rent
from
other widely used silicon compounds (e.g. sodium silicate, sodium
aluminosilicate, etc.).
Chemistry and Environmental Levels
A k
now
led
ge
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for
pro
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eva
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res
ult
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rom
tox
ico
log
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l e
xpe
rim
ent
s.
* Contributed by G.C. Becking
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l
t
r
a
n
s
f
o
r
m
to
a
m
o
r
p
h
o
u
s
a
l
u
m
i
n
a
t
e
s
(
c
l
a
y
-
l
i
k
e
m
a
t
e
r
i
a
l
s
)
and
s
o
d
i
u
m
s
i
l
i
c
a
t
e
s
.
The
p
r
e
s
e
n
c
e
of
protons
or
c
h
e
l
a
t
o
r
s
in
the
e
n
vi
r
o
n
m
e
n
t
will
e
n
h
a
n
c
e
the
removal
of
s
i
l
i
c
a
t
e
s
f
r
o
m
t
h
e
c
u
b
o
i
d
a
l
s
t
r
u
c
t
u
r
e
,
d
e
s
t
r
o
y
i
n
g
t
h
e
r
i
g
i
d
c
u
b
i
c
s
t
r
u
c
t
u
r
e
.
At
pH
<5
t
h
e
t
r
a
n
s
f
o
r
m
a
t
i
o
n
t
a
k
e
s
p
l
a
c
e
in
a
f
e
w
s
e
c
o
n
d
s
,
and
at
pH
v
a
l
u
e
s
b
e
t
we
e
n
5
and
8,
the
rate
is
fast,
but
m
a
y
take
a
few
m
i
n
ut
e
s
to
complete.
At
a
pH
a
b
o
v
e
8
t
h
e
s
a
m
e
t
r
a
n
s
f
o
r
m
a
t
i
o
n
o
c
c
u
r
s
b
ut
at
a
s
l
o
w
e
r
rate.
G
i
v
e
n
t
h
i
s
i
n
s
t
a
b
i
l
i
t
y
,
c
u
b
o
i
d
a
l
T
y
p
e
A
Z
e
o
l
i
t
e
wi
l
l
r
a
r
e
l
y
be
f
o
u
n
d
in
t
h
e
e
n
v
i
r
o
n
m
e
n
t
.
It
wi
l
l
r
a
p
i
d
l
y
t
r
a
n
s
f
o
r
m
to
a
m
o
r
p
h
o
u
s
a
l
u
m
i
n
a
t
e
s
and
s
o
l
u
b
l
e
s
i
l
i
c
a
t
e
s
u
n
d
e
r
t
h
e
a
c
i
d
c
o
n
d
i
t
i
o
n
s
of
t
h
e
s
t
o
m
a
c
h
a
n
d
t
h
e
n
e
u
t
r
a
l
c
o
n
d
i
t
i
o
n
s
o
f
o
t
h
e
r
t
i
s
s
u
e
s
and
t
h
e
g
e
n
e
r
a
l
e
n
v
i
r
o
n
m
e
n
t
.
B
o
t
h
t
r
a
n
s
f
o
r
m
a
t
i
o
n
p
r
o
d
u
c
t
s
h
a
v
e
an
e
x
t
e
n
s
i
v
e
h
i
s
t
o
r
y
o
f
s
a
f
e
us
a
g
e
.
In
t
h
e
U
n
i
t
e
d
S
t
a
t
e
s
,
t
h
e
m
e
d
i
a
n
l
e
v
e
l
s
o
f
s
o
l
u
b
l
e
s
i
l
i
c
a
t
e
(
m
e
a
s
u
r
e
d
as
SlOz)
and
s
o
l
ub
l
e
a
l
um
i
n
a
t
e
(measured
as
Al)
are
7.1
m
g
/
L
and
0
.
0
5
4
mg/L
r
e
s
p
e
c
t
i
v
e
l
y
.
A
s
s
u
m
i
n
g
an
e
x
a
g
g
e
r
a
t
e
d
u
s
e
p
a
t
t
e
r
n
,
t
h
a
t
is,
w
h
e
r
e
all
d
e
t
e
r
g
e
n
t
s
w
e
r
e
b
u
i
l
t
w
i
t
h
20
p
e
r
c
e
n
t
T
y
p
e
A
Z
e
o
l
i
t
e
,
e
n
v
i
r
o
n
m
e
n
t
a
l
s
t
u
d
i
e
s
s
h
o
w
e
d
t
h
a
t
t
r
a
n
s
f
o
r
m
a
t
i
o
n
p
r
o
d
u
c
t
s
w
o
u
l
d
r
e
s
u
l
t
in
0
.
0
0
0
0
3
m
g
/
L
A
l
/
L
and
0
.
0
0
0
0
7
m
g
/
L
S
i
0
2
in
p
o
t
a
b
l
e
w
a
t
e
r
.
T
h
e
s
e
f
i
n
d
i
n
g
s
h
a
v
e
b
e
e
n
c
o
n
f
i
r
m
e
d
in
b
o
t
h
l
a
b
o
r
a
t
o
r
y
and
p
i
l
o
t
s
c
a
l
e
s
t
u
d
i
e
s
of
d
r
i
n
k
i
n
g
w
a
t
e
r
t
r
e
a
t
m
e
n
t
p
r
o
c
e
s
s
e
s
a
n
d
c
o
n
d
i
t
i
o
n
s
.
N
o
p
a
r
t
i
c
l
e
s
r
e
s
e
m
b
l
i
n
g
t
h
e
c
u
b
o
i
d
a
l
s
t
r
u
c
t
u
r
e
o
f
T
y
p
e
A
Z
e
o
l
i
t
e
h
a
v
e
b
e
e
n
f
o
u
n
d
in
t
h
e
s
e
s
t
u
d
i
e
s
.
Acute Toxicity
E
x
t
e
n
s
i
v
e
a
c
u
t
e
t
o
x
i
c
i
t
y
s
t
u
d
i
e
s
o
n
T
y
p
e
A
Z
e
o
l
i
t
e
i
n
d
i
c
a
t
e
t
h
a
t
t
h
i
s
m
a
t
e
r
i
a
l
is
a
n
a
c
u
t
e
l
y
n
o
n
t
o
x
i
c
c
h
e
m
i
c
a
l
(
5
)
.
It
is
n
o
n
-
t
o
x
i
c
w
h
e
n
i
n
g
e
s
t
e
d
in
a
s
i
n
g
l
e
d
o
s
e
a
n
d
is
r
e
l
a
t
i
v
e
l
y
n
o
n
-
i
r
r
i
t
a
t
i
n
g
t
o
t
h
e
e
y
e
a
n
d
s
k
i
n
.
T
y
p
e
A
Z
e
o
l
i
t
e
d
o
e
s
n
o
t
p
r
o
d
u
c
e
s
e
n
s
i
t
i
z
a
t
i
o
n
a
n
d
is
n
o
n
—
i
r
r
i
t
a
t
i
n
g
t
o
t
h
e
r
e
s
p
i
r
a
t
o
r
y
s
y
s
t
e
m
a
f
t
e
r
a
s
i
n
g
l
e
i
n
h
a
l
a
t
i
o
n
e
x
p
o
s
u
r
e
.
T
h
e
s
t
u
d
i
e
s
o
n
w
h
i
c
h
t
h
e
a
b
o
v
e
c
o
n
c
l
u
s
i
o
n
s
w
e
r
e
m
a
d
e
a
r
e
s
u
m
m
a
r
i
z
e
d
in
T
a
b
l
e
l.
 
&
k
 Test
Oral LDso
Oral toxicity (Dog)
Eye irritation (Rabbit)
3 mg unrinsed
3 mg rinsed
0.1 mL of 10% aqueous
Eye irritation (Monkey)
35 mg unrinsed
Rin irritation (Rabbit)
Abraded and Non—Abraded
Slightly
moistened;
20%
aqueous
slurry Zeolite A 24-hour,
closed patch
‘ win irritation (Human)
Single
patch,
50%
aqueous
slurry
Mute
Percutaneous
Toxicity
(
Abraded and Non—abraded
2
g/kg;
24—hour
closed
patch
Rabbit)
knsitization
(Guinea
Pig)
50% aqueous slurry
(3 weekly applications and
challenge)
%
n
s
i
t
i
z
a
t
i
o
n
(
H
u
m
a
n
s
)
5% aqueous slurry
(9 weekly applications and
challenge)
M
u
t
e
i
n
h
a
l
a
t
i
o
n
(
R
a
t
s
)
Single l-hr exposure: 2.4 and
18.3 mg/L
Single
4-hr
exposure;
0.08
and
0.14 mg/L
k
u
t
e
i
n
t
r
a
t
r
a
c
h
e
a
l
i
n
s
t
i
l
l
a
t
i
o
n
(
R
a
t
s
)
m
vitro
(Rabbits)
and
in
vivo
(Rats
and
Hamsters)
alveolar
macrophage
 
TABLE 1
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A
C
U
T
E
O
R
A
L
,
D
E
R
M
A
L
,
O
C
U
L
A
R
,
A
N
D
I
N
H
A
L
A
T
I
O
N
S
T
U
D
I
E
S
Results
>
2
7
.
0
g
/
k
g
;
n
o
l
e
t
h
a
l
i
t
y
a
t
2
7
g
/
k
g
1
g
/
k
g
p
r
o
d
u
c
e
d
s
l
i
g
h
t
h
y
p
e
r
e
m
i
a
o
f
s
t
o
m
a
c
h
Non-irritating
Slight
irritation
which
subsided
within
48 hours
Mild
irritation
consisting
of
mild
erythema
Non-irritating
No
deaths;
mild
erythema
at
treatment
site
No sensitization
No sensitization
No observable toxic effects
No observable toxic effects
Irritation potential of Type A Zeolite is
similar to calcium carbonate and less than
silica flour
Toxicity rating: TYPE A Zeolite<Clay<Quartz
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M
e
t
a
b
o
l
i
s
m
a
n
d
S
u
b
c
h
r
o
n
i
c
T
o
x
i
c
i
t
y
S
t
u
d
i
e
s
B
o
t
h
a
c
u
t
e
a
n
d
s
u
b
-
c
h
r
o
n
i
c
m
e
t
a
b
o
l
i
c
s
t
u
d
i
e
s
h
a
v
e
b
e
e
n
c
o
n
d
u
c
t
e
d
o
n
T
y
p
e
A
Z
e
o
l
i
t
e
i
n
r
a
t
,
m
o
n
k
e
y
a
n
d
m
a
n
t
o
d
e
t
e
r
m
i
n
e
i
t
s
a
b
s
o
r
p
t
i
o
n
,
d
i
s
t
r
i
b
u
t
i
o
n
a
n
d
e
x
c
r
e
t
i
o
n
p
a
t
t
e
r
n
.
A
d
d
i
t
i
o
n
a
l
l
y
,
r
e
a
c
t
i
o
n
s
to
T
y
p
e
A
Z
e
o
l
i
t
e
in
a
m
o
d
e
l
h
u
m
a
n
s
t
o
m
a
c
h
w
e
r
e
s
t
u
d
i
e
d
,
a
s
w
a
s
t
h
e
r
e
l
a
t
i
o
n
s
h
i
p
b
e
t
w
e
e
n
t
h
e
c
o
n
c
e
n
t
r
a
t
i
o
n
o
f
s
o
l
u
b
l
e
a
n
d
p
a
r
t
i
c
u
l
a
t
e
s
i
l
i
c
o
n
s
p
e
c
i
e
s
in
h
u
m
a
n
u
r
i
n
e
a
n
d
t
h
e
l
e
v
e
l
o
f
s
i
l
i
c
o
n
in
p
o
t
a
b
l
e
w
a
t
e
r
.
A
s
u
m
m
a
r
y
o
f
t
h
e
v
a
r
i
o
u
s
m
e
t
a
b
o
l
i
c
t
e
s
t
s
w
a
s
p
r
e
s
e
n
t
e
d
to
t
h
e
I
J
C
T
a
s
k
F
o
r
c
e
b
y
t
h
e
P
r
o
c
t
e
r
a
n
d
G
a
m
b
l
e
C
o
m
p
a
n
y
(
2
,
3
)
a
n
d
is
r
e
p
r
o
d
u
c
e
d
w
i
t
h
m
i
n
o
r
c
h
a
n
g
e
s
in
T
a
b
l
e
2.
TABLE 2
M
e
t
a
b
o
l
i
s
m
S
t
u
d
i
e
s
T
e
s
t
R
e
s
u
l
t
s
S
t
o
m
a
c
h
M
o
d
e
l
-
H
u
m
a
n
—
T
y
p
e
A
Z
e
o
l
i
t
e
i
s
h
y
d
r
o
l
y
z
e
d
t
o
a
l
u
m
i
n
a
t
e
s
and silicates
A
c
u
t
e
(
s
i
n
g
l
e
d
o
s
e
)
-
U
r
i
n
a
r
y
s
i
l
i
c
o
n
m
a
r
k
e
d
l
y
i
n
c
r
e
a
s
e
d
,
r
a
t
a
n
d
m
o
n
k
e
y
:
0
,
4
0
,
2
0
0
o
r
1
0
0
0
m
g
u
r
i
n
a
r
y
a
l
u
m
i
n
u
m
u
n
c
h
a
n
g
e
d
T
y
p
e
A
Z
e
o
l
i
t
e
/
k
g
—
8
5
-
1
1
0
%
o
f
d
o
s
e
d
a
l
u
m
i
n
u
m
f
o
u
n
d
in
r
a
t
f
e
c
m
'
m
a
n
:
0
o
r
4
0
m
g
T
y
p
e
A
Z
e
o
l
i
t
e
/
k
g
-
In
m
a
n
,
b
l
o
o
d
Al
<
1
u
g
/
m
L
a
f
t
e
r
s
i
n
g
l
e
40 mg/kg dose
-
S
i
m
i
l
a
r
u
r
i
n
a
r
y
s
i
l
i
c
o
n
e
x
c
r
e
t
i
o
n
(%
o
f
d
o
w
l
i
n
a
l
l
3
s
p
e
c
i
e
s
S
u
b
—
c
h
r
o
n
i
c
in
r
a
t
s
-
I
n
c
r
e
a
s
e
in
u
r
i
n
a
r
y
s
i
l
i
c
o
n
;
u
r
i
n
a
r
y
0
a
n
d
2
%
i
n
d
i
e
t
-
8
w
e
e
k
s
a
l
u
m
i
n
u
m
u
n
c
h
a
n
g
e
d
-
N
o
s
i
g
n
i
f
i
c
a
n
t
t
i
s
s
u
e
s
t
0
r
a
g
e
o
f
a
l
u
m
i
n
u
m
-
N
o
k
i
n
e
t
i
c
e
v
i
d
e
n
c
e
f
o
r
m
u
l
t
i
p
l
e
t
i
s
s
u
e
b
i
n
d
i
n
g
s
i
t
e
s
f
o
r
s
i
l
i
c
o
n
 
Excretion
of
ur
i
n
a
r
y
p
a
r
t
i
c
ul
a
t
e
—
A
m
a
r
k
e
d
i
n
cr
e
as
e
in
e
xc
r
e
t
i
o
n
of
particulae-
S
i
l
i
c
o
n
(
r
a
t
s
)
;
0,
0
.
1
2
5
,
0
.
2
5
,
0
.
5
,
s
i
l
i
c
o
n
n
o
t
e
d
at
0
.
1
2
5
—
0
.
2
5
%
T
y
p
e
A
Z
e
o
l
ﬁ
e
1
a
n
d
2
%
i
n
d
i
e
t
3
-
1
6
w
e
e
k
s
H
u
m
a
n
U
r
i
n
a
r
y
S
i
l
i
c
o
n
-
E
x
c
r
e
t
i
o
n
—
D
r
i
n
k
i
n
g
w
a
t
e
r
s
i
l
i
c
o
n
(
m
e
d
i
a
n
l
e
v
e
l
7
m
g
/
U
l
in
r
e
l
a
t
i
o
n
t
o
d
r
i
n
k
i
n
g
w
a
t
e
r
d
o
e
s
n
o
t
a
f
f
e
c
t
u
r
i
n
a
r
y
p
a
r
t
i
c
u
l
a
t
e
s
i
l
i
c
o
n
s
i
l
i
c
o
n
l
e
v
e
l
s
e
x
c
r
e
t
i
o
n
-
<
1
p
g
/
L
s
i
l
i
c
o
n
c
o
n
t
r
i
b
u
t
e
d
t
o
d
r
i
n
k
i
n
g
water
through
use
of
Type
A
Zeolite
would
increase
urinary
excretion
of
soluble
silica
<0.02%.
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Acute
and
sub—chronic
metabolic
studies
have
been
conducted
with
Type
A
Zeolite and other silicon containing compounds, such as sodium silicate,
magnesium
trisilicate
and food
grade
sodium
aluminosilicate,
which
have
been
approved as safe for food use by the U.S. Food and Drug Administration (FDA),
the
WHO
and
other
international
agencies.
The
above
studies
indicate
that
Type A Zeolite is hydrolyzed in the stomach to silicates and aluminates and
only the silicon moiety of Type A Zeolite is partially absorbed.
The acute studies show that,
as the dose of Type A Zeolite is increased,
urinary silicon excretion is increased. Aluminum is recovered in the feces.
This fecal aluminum represents unabsorbed aluminum, since analysis of bile
from animals dosed with Type A Zeolite show that bile is not a route of
excretion for Type A Zeolite.
Urinary excretion of silicon, expressed as percent of silicon dosed, was
similar for rat, monkey and man when dosed with a single large dose of Type A
Zeolite. To this extent the rat is an appropriate model for chronic toxicity
studies on Type A Zeolite.
The sub-chronic metabolic studies conducted in rats provide additional
support for the conclusion that Type A Zeolite is hydrolyzed in the stomach to
silicates and aluminates and that only the silicon moiety of Type A Zeolite is
absorbed. These studies show that as the dose of Type A Zeolite in the rat
diet is increased, the amount of silicon excreted in the urine is markedly
increased while urinary aluminum and tissue aluminum remain unchanged.
Urinary silicon excretion is such that at dietary concentrations greater than
0.12
5% T
ype
A Ze
olit
e,
the
urin
ary
sili
con
burd
en b
ecom
es s
o gr
eat
that
the
urine becomes saturated with soluble silicate and silicate precipitation
occu
rs
in t
he u
rine
(ref
erre
d to
here
in a
s "p
arti
cula
te"
sili
con)
.
A human urinary silicon monitoring program investigating the relationship
bet
wee
n n
atu
ral
lev
els
of
sil
ico
n i
n t
he
dri
nki
ng
wat
er
(1-
10
ppm
SiOz
)
and
the
exc
ret
ion
of
sol
ubl
e a
nd
"pa
rti
cul
ate
" s
ili
con
(si
lic
on
pre
cip
ita
te
>0.
4u)
in
the
uri
ne
sho
ws
tha
t d
rin
kin
g w
ate
r c
ont
ain
ing
up
to 1
0 p
pm
510
2 h
as
no
eff
ect
on
uri
nar
y "
par
tic
ula
te"
sil
ico
n e
xcr
eti
on,
thu
s
ind
ica
tin
g t
hat
the
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 parts
per
billion
of
silicon
added
to
the
drinking
water
through
the
large
scale
use
of
Type
A
Zeolite
in
the
detergent
industry
is
not
likely
to
cause
an
increase
in
urinary
"particulate"
silicon.
The
above
extensive
metabolic
experiments
in
several
species,
including
man,
have
provided
ample
proof
that
the
oral
toxicity
of
Type
A
Zeolite
is
that
of
soluble
silicates.
Also,
the
sub-chronic
feeding
studies,
in
which
rats
were
fed
diets
containing
0.1
to
2%
Type
A
Zeolite
for
periods
of
time
between
90
and
200
days,
indicate
that
Type
A
Zeolite
is
a
relatively
non-toxic
chemical.
Significant
toxic
manifestatons
were
only
noted
at
doses
producing
high
levels
of
urinary
particulate
silicon.
In
Cox
or
Long
Evans
rats,
dietary
levels
of
Zeolite
A
as
high
as
2%
failed
to
cause
dose
related
effects
on
organ
weights,
hematology,
blood
chemistry
or
kidney
function
after
168
or
200
days.
Body
weights
of
animals
receiving
2%
Type
A
Zeolite
were
lower
than
controls.
Also,
an
increased
urine
volume
and
decreased
specific
gravity
were
noted
in
animals
receiving
2%
Zeolite
in
the
diet.
Siliceous
particles
were
noted
in
the
urine
of
all
rats
receiving
>0.125%
Type
A
Zeolite
in
the
diet.
The
quantity
of
particles
a
p
p
e
a
r
i
n
g
in
the
urine
was
dose
related.
A
d
d
i
t
i
o
n
a
l
l
y,
at
d
i
e
t
a
r
y
levels
greater
than
0
.
1
2
5
%
Type
A
Zeolite,
the
s
i
l
i
c
e
o
us
p
a
r
t
i
c
l
e
s
a
g
g
r
e
g
a
t
e
d
to
form
bladder
and
k
i
d
n
e
y
stones.
Such
stones
did
not
appear
until
a
f
t
e
r
90
days
on
t
e
s
t
and
the
i
n
c
i
d
e
n
c
e
o
f
s
t
o
n
e
s
i
n
c
r
e
a
s
e
d
w
i
t
h
t
i
m
e
and
d
i
e
t
a
r
y
l
e
v
e
l
s
a
b
o
v
e
0.125%.
B
e
l
o
w
this
"
t
h
r
e
s
h
o
l
d
"
d
i
e
t
a
r
y
level
for
p
a
r
t
i
c
l
e
f
o
r
m
a
t
i
o
n
,
no
c
o
m
p
o
u
n
d
r
e
l
a
t
e
d
s
t
o
n
e
s
w
e
r
e
o
b
s
e
r
v
e
d
.
T
h
e
p
a
r
t
i
c
l
e
s
and
s
t
o
n
e
s
w
e
r
e
a
m
o
r
p
h
o
u
s
,
h
i
g
h
in
s
i
l
i
c
o
n
c
o
n
t
e
n
t
,
w
i
t
h
no
d
e
t
e
c
t
a
b
l
e
a
l
u
m
i
n
u
m
.
C
o
m
p
o
u
n
d
r
e
l
a
t
e
d
m
i
c
r
o
s
c
o
p
i
c
c
h
a
n
g
e
s
w
e
r
e
o
b
s
e
r
v
e
d
in
t
h
e
k
i
d
n
e
y
s
a
n
d
/
o
r
b
l
a
d
d
e
r
s
of
a
n
i
m
a
l
s
r
e
c
e
i
v
i
n
g
g
r
e
a
t
e
r
t
h
a
n
0
.
1
2
5
%
T
y
p
e
A
Z
e
o
l
i
t
e
in
t
h
e
d
i
e
t
f
o
r
168
or
2
0
0
d
a
ys
.
T
h
e
m
i
c
r
o
s
c
o
p
i
c
c
h
a
n
g
e
s
c
o
n
s
i
s
t
e
d
of
h
y
p
e
r
p
l
a
s
i
a
of
the
t
r
a
n
s
i
t
i
o
n
a
l
cell
e
p
i
t
h
e
l
i
u
m
of
t
h
e
m
u
c
o
s
a
of
t
h
e
u
r
i
n
a
r
y
b
l
a
d
d
e
r
and
t
h
e
k
i
d
n
e
y
pelvic
epithelium.
When
such
changes
were
found
p
a
r
t
i
c
ul
a
t
e
material
or
c
a
l
c
u
l
i
w
e
r
e
a
l
s
o
f
o
u
n
d
.
A
l
s
o
,
a
f
t
e
r
m
i
c
r
o
s
c
o
p
i
c
e
x
a
m
i
n
a
t
i
o
n
of
t
h
e
k
i
d
n
e
y
,
u
r
e
t
e
r
s
and
u
r
i
n
a
r
y
b
l
a
d
d
e
r
of
a
n
i
m
a
l
s
r
e
c
e
i
v
i
n
g
2%
T
y
p
e
A
Z
e
o
l
i
t
e
in
t
h
e
d
i
e
t
,
a
l
t
e
r
a
t
i
o
n
s
c
h
a
r
a
c
t
e
r
i
z
e
d
b
y
an
i
n
c
r
e
a
s
e
in
t
h
e
i
n
c
i
d
e
n
c
e
a
n
d
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severity
of
interstitial
nephritis
and
regenerative
epithelium
were
noted.
No
histopathological
lesions
were
found
in
animals fed
diets containing
0.125%
Zeolite
A.
The
microscopic
changes
appeared
to
be
related
to
the
urinary
silicate
burden
and
siliceous
material
in
the
tissues.
They
were
similar
to
those
reported
for
other
silicates,
such
as
sodium
silicate,
magnesium
trisilicate and silicic acid.
Twenty—eight-day
and
91-day
dermal
toxicity
studies
conducted
in
rabbits
showed that Type A Zeolite had no systemic or dermal effects.
Application of
2 mL/kg
bodyweight
of
a
10%
aqueous
slurry
of
Type
A
Zeolite
to
the
backs
of
rabbits 6 hr/day, 5 days per week for 4 or 13 weeks was non-irritating to the
skin and had no adverse effect on bodyweight, hematology, clinical chemistry
or histology.
Chronic Toxicity
Based on sub—chronic metabolic studies and 200 day sub-chronic feeding
studies, the highest dietary dose level used in chronic studies was 0.1%.
This should be considered a maximum tolerated dose, since higher levels result
in siliceous material causing physical tissue damage. The exact effect of
such non-physiological action on chronic toxicity is unknown.
Administration of 0.001%, 0.01% and 0.1% Type A Zeolite in the diet of
Wistar rats for 78 weeks had no compound related effects on physical
appearance, hematology, blood chemistry or urinalysis.
Gross necropsy of animals revealed no abnormal findings. This study
cannot be considered an adequate chronic toxicity study, but the
carcinogenicity bioassay (using a similar dosing regimen) utilized an
experimental design, making it a combined carcinogenicity and 104 week chronic
 
toxicity study.
In t
he c
arci
noge
nici
ty b
ioas
say,
resu
lts
of b
lood
chem
istr
y, h
emat
olog
y,
urinalysis and body weight/food consumption studies, as well as the
hist
opat
holo
gica
l e
xami
nati
on f
or n
on—c
ance
rous
lesi
ons,
supp
ort
the
resu
lts
63
 of the 78 week chronic experiment.
That is, the administration of 0.1% Type A
Zeolite in the diet for 104 weeks does not produce chronic toxicity in rats*.
No evidence of fibrosis was observed in hamsters exposed to =20 mg/m3
of Type A Zeolite, 3 days per week, 5 hours per day for 52 weeks. The only
observation was the presence of the test material in the alveolar macrophage
and lymph nodes.
Exposure of Cynomolgus monkeys to 1 and 6 mg/m3 of Type A Zeolite or
Type A Zeolite detergent (detergent micronized to maximize inhalation) for
24—months and to 50 mg/m3 of Type A Zeolite or quartz for 12 months had no
adverse effects on bodyweight gain, hematology, serum chemistry or
urinalysis.
The only alteration in pulmonary function was a decrease in the
mean vital capacity of the monkeys exposed to quartz for 12 months.
Histopathology of the various tissues indicated that exposure to =1 and 6
mg/m3 of Type A Zeolite-containing detergents for 6 hours per day, 5 days
per week
for 104 weeks produced only an increase in alveolar and septal
macrophages. Exposure to =1 and 6 mg/m3 Type A Zeolite for 104 weeks and
=50 mg/m3 Type A Zeolite for 52 weeks produced an increase in alveolar and
septal marcrophages.
In addition, at the 6 and 50 mg/m3 Type A Zeolite
doses,
sporadic inflammatory reactions were observed
in the
lungs of some of
the treated animals.
These inflammatory reactions were observed primarily in
lobes of the lung previously compromised by mites and kaolin.
Neither Type A
Zeolite nor Type A Zeolite-containing detergents produced pulmonary fibrosis
after 104 weeks of exposure.
Compound
related effects were not observed
in any other tissues.
Quartz
produced progressive pulmonary fibrosis in monkeys as early as 30 weeks after
initial
exposure.
The observed
increase in alveolar and septal macrophages
with Type A Zeolite and Type A Zeolite detergents is a classical
pulmonary
clearance response to relatively
innocuous,
insoluble, materials
deposited in
the lungs.
These results support the conclusion that Type A Zeolite and Type
A Zeolite-containing detergents
are relatively innocuous materials.
*
Personal
Communication from the Procter and Gamble Company,
regarding
information
supplied
to
them
by the
Henkel
Company.
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Carcinogenicity
To
d
e
t
e
r
m
i
n
e
the
c
a
r
c
i
n
o
g
e
n
i
c
potential
of
Type
A
Zeolite,
it
was
administered
at
0.001,
0.01
and
0.1%
in
the
diet
of
rats
for
104
weeks.
At
the
0.1%
dose
there
was
an
exacerbation
of
glomerulonephrosis,
a
sponta—
neous
kidney
disease
which
develops
in
aging
rats.
The
0.1%
dose
is
considered
a
maximum
tolerated
dose
because
of
the
reported
exacerbation
of
this
spontaneous
kidney
disease
in
female
rats
and
because
it
is
the
“breakpoint”
at
which
there
is
an
increase
in
particulate
silicon
in
the
urine
which
could
lead
to
stone
formation,
compromising
the
carcinogenic
assessment
in bladder and kidneys.
Tumor
incidence
was
reported
to
be
essentially
identical
among
groups
and
sexes
whether
broken
down
as
total
tumors,
malignant
tumors
or
benign
tumors.
No
treatment
associated
carcinogenicity
was
identifiable.
Mesenteric-lymphangiomas
and
pituitary
tumors
were
the
most
common
tumors
in males,
whereas
pituitary
tumors
were
the
most
prevalent
type
of
tumor
in
females.
In
both
cases,
no
treatment
associated
or
dose-response
associated
carcinogenic effect was reported.
In conclusion, an essentially lifetime feeding study which was designed
and conducted in a fashion similar to those in the NCI's bioassay program has
yielded data strongly supporting the conclusion that the chronic feeding of
high doses of Type A Zeolite does not produce cancer or chronic organ toxicity
in rodents.
No carcinogenic or fibrogenic effects were observed in rats exposed to
=20 mg/m3 of Type A Zeolite, for three days per week, 5 hours per day for
22 months. The only compound related effect observed was the presence of the
test material in the alveolar macrophage and the lymph nodes, indicative of
detoxification mechanisms for airborne foreign insoluble particulate matter.
No carcinogenic effects were observed in rats given a single 50 mg
intraperitoneal injection of quartz or Type A Zeolite and then observed for
65
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 v
a
r
i
o
u
s
t
i
m
e
p
e
r
i
o
d
s
u
p
t
o
2
4
m
o
n
t
h
s
.
U
n
d
e
r
t
h
e
a
b
o
v
e
d
o
s
i
n
g
c
o
n
d
i
t
i
o
n
s
,
T
y
p
e
A
Zeolite
produced
a
fibrogenic
response
within
the
peritoneal
cavity.
The
r
e
s
p
o
n
s
e
was
q
u
a
l
i
t
a
t
i
v
e
l
y
and
q
u
a
n
t
i
t
a
t
i
v
e
l
y
d
i
f
f
e
r
e
n
t
f
r
o
m
the
f
i
b
r
o
g
e
n
i
c
response
produced
by
quartz.
Specifically,
the
response
observed
with
TypeA
Z
e
o
l
i
t
e
r
e
g
r
e
s
s
e
d
with
time,
wh
e
r
e
a
s
the
r
e
s
p
o
n
s
e
after
a
d
m
i
n
i
s
t
r
a
t
i
o
n
of
q
u
a
r
t
z
p
r
o
g
r
e
s
s
e
d
w
i
t
h
t
i
m
e
.
U
n
p
u
b
l
i
s
h
e
d
,
p
r
e
l
i
m
i
n
a
r
y
s
t
u
d
i
e
s
,
u
t
i
l
i
z
i
n
g
this
t
e
c
h
n
i
q
ue
in
mice,
f
o
un
d
that
an
i
n
t
r
a
p
e
r
i
t
o
n
e
a
l
i
n
j
e
c
t
i
o
n
of
20
mg
of
fibrous
natural
zeolite
resulted
in
the
production
of
mesotheliomas
in
less
than
one
year
(Personal
C
o
m
m
un
i
c
a
t
i
o
n
—
Dr.
I.
Selikoff).
It
is
thus
a
valid
model
to
indicate
carcinogenic
or
toxic
potential
of
relatively
insoluble
materials.
The
e
f
f
e
c
t
s
of
c
h
r
o
n
i
c
i
n
h
a
l
a
t
i
o
n
of
Z
e
o
l
i
t
e
A
c
o
n
t
a
i
n
i
n
g
d
e
t
e
r
g
e
n
t
f
o
r
m
ul
a
t
i
o
n
s
were
s
t
ud
i
e
d
in
m
o
n
k
e
ys
e
xp
o
s
e
d
to
1
and
6mg/m3
of
these
materials.
Exposure
was
for
6
hrs/day,
5
days
per
week
for
104
weeks.
None
of
the
test
m
a
t
e
r
i
a
l
s
had
a
d
ve
r
s
e
e
f
f
e
c
t
s
on
b
o
d
y
we
i
g
h
t
gain,
hematology,
serum
c
h
e
m
i
s
t
r
y
or
urinalysis.
The
o
n
l
y
a
l
t
e
r
a
t
i
o
n
in
p
u
l
m
o
n
a
r
y
f
un
c
t
i
o
n
was
noted
in
m
o
n
k
e
ys
t
r
e
a
t
e
d
with
quartz.
H
i
s
t
o
p
a
t
h
o
l
o
g
i
c
a
l
e
xa
m
i
n
a
t
i
o
n
of
the
various
tissues
i
n
d
i
c
a
t
e
d
that
e
xp
o
s
ur
e
to
a
p
p
r
o
x
i
m
a
t
e
l
y
1
and
6
mg/m3
of
Type
A
Zeolite,
or
detergent
formulations
with
Zeolite
A
produced
only
an
increase
in
a
l
ve
o
l
a
r
and
septal
m
a
c
r
o
p
h
a
g
e
s
,
and
the
e
xp
e
c
t
e
d
r
e
s
p
o
n
s
e
to
inhaled
insoluble
p
a
r
t
i
c
ul
a
t
e
matter.
T
h
e
s
e
i
n
h
a
l
a
t
i
o
n
studies
in
m
o
n
k
e
ys
s
u
p
p
o
r
t
t
h
e
c
o
n
c
l
u
s
i
o
n
t
h
a
t
c
h
r
o
n
i
c
e
x
p
o
s
u
r
e
to
T
y
p
e
A
Z
e
o
l
i
t
e
d
u
s
t
s
p
o
s
e
s
a
negligible
health
hazard.
Mutagenicity
No
m
u
t
a
g
e
n
i
c
i
t
y
t
e
s
t
s
on
T
y
p
e
A
Z
e
o
l
i
t
e
h
a
v
e
b
e
e
n
r
e
p
o
r
t
e
d
.
F
o
o
d
g
r
a
d
e
s
o
d
i
um
a
l
um
i
n
o
s
i
l
i
c
a
t
e
has
been
f
o
un
d
n
o
n
-
m
ut
a
g
e
n
i
c
in
host
m
e
d
i
a
t
e
d
assays
w
i
t
h
S
a
l
m
o
n
e
l
l
a
t
y
p
h
i
m
u
r
i
u
m
and
S
a
c
c
h
a
r
o
m
y
c
e
s
c
e
r
e
v
i
s
i
a
e
as
well
as
a
d
o
m
i
n
a
n
t
lethal
assay
in
which
male
rats
were
intubated
with
4.25,
42.5
or
425
mg/kg
of
s
o
d
i
u
m
a
l
u
m
i
n
o
s
i
l
i
c
a
t
e
d
a
i
l
y
f
o
r
5
d
a
y
s
p
r
i
o
r
t
o
m
a
t
i
n
g
.
 
S
i
l
i
c
o
n
d
i
o
x
i
d
e
a
n
d
h
y
d
r
a
t
e
d
c
a
l
c
i
u
m
s
i
l
i
c
a
t
e
d
i
d
n
o
t
i
n
d
u
c
e
m
u
t
a
t
i
o
n
s
in
t
h
e
h
o
s
t
m
e
d
i
a
t
e
d
a
s
s
a
y
w
i
t
h
S
a
l
m
o
n
e
l
l
a
t
y
p
h
i
m
u
r
i
u
m
or
S
a
c
c
h
a
r
o
m
y
c
e
s
c
e
r
e
v
i
s
i
a
e
,
n
o
r
d
i
d
t
h
e
s
e
t
w
o
s
i
l
i
c
o
n
m
a
t
e
r
i
a
l
s
p
r
o
d
u
c
e
s
i
g
n
i
f
i
c
a
n
t
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 aberrations
in
the
bone
marrow
metaphase
chromosomes
of
rats;
nor
did
they
produce
abnormal
changes
in
anaphase
chromosomes
of
human
embryonic
lung
cells
in tissue culture.
Based
on
the
fact
that
other
silicates
are
non-mutagenic,
it
is
unlikely
that
Type
A
Zeolite
would
be
positive
in
mutagenicity
tests.
Teratology
In
the
rat
teratology
study,
dams
were
given
either
74
mg/kg or
1600 mg/kg
Type A Zeolite by gavage on days 6-15 of gestation inclusive.
In the rabbit
teratology study, dams were given 74 mg/kg,
345 mg/kg or 1600 mg/kg of Type A
Zeolite on days 6 through 18 of gestation.
Like other silicates, Type A
Zeolite has a teratogenic potential comparable to food grade sodium
aluminosilicate.
Conclusions
The toxicological data base on Type A Zeolite is much more extensive than
that available for other synthetic and natural silicates, even those used by
the food industry. Type A Zeolite is essentially non-toxic via oral, dermal,
ocular and respiratory routes of exposure and adverse effects are noted only
after oral doses several million times that of calculated human exposures.
These effects are similar to those noted after administration of massive oral
doses of other widely used silicates (e.g. magnesium trisilicate, food grade
sodium aluminosilicate and sodium silicate).
Laboratory and environmental studies have shown that man will not be
exposed to cuboidal Type A Zeolite, only to soluble silicates and insoluble
aluminates (clay-like material). Extensive metabolic studies have shown that
only the silicate, but not the aluminate, moiety of Type A Zeolite is
absorbed; supporting the conclusion that the oral toxicity of Type A Zeolite
is that of soluble silicate.
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The
median
level
of
Si02
in
drinking
water
is
7
mg/L.
Assuming
an
exaggerated
use
pattern
for
Type
A
Zeolite
in
detergents,
this
level
of
silicon
will
increase
by
less
than
0.001%.
During
animal
studies,
marked
histopathological
lesions
were
noted
only
in
the
kidney
and
bladder
from
animals
fed
diets
containing
Type
A
Zeolite
at
levels
exceeding
0.125
percent.
Such
dose
levels
lead
to
increased
particulate
silicon
and
frank
kidney
and
bladder
stones
after
90
days.
Naturally
occurring
levels
of
silicon
in
drinking
water
(up
to
10
mg/mL)
have
not
been
shown
to
lead
to
detectable
levels
of
urinary
particulate
silicon.
Type
A
Zeolite
is
not
a
teratogen
and
is
not
carcinogenic
orally
or
via
the
inhalation
route
of
exposure.
The
negative
mutagenic
activity
noted
in
other
silicates
make
it
highly
unlikely
that
Type
A
Zeolite
poses
a
mutagenic
hazard.
As
with
other
builders,
based
on
present
knowledge
and
using
current
state-of-the-art
techniques
of
toxicological
assessment,
it
is
concluded
that
the
use
of
Type
A
Zeolite
in
detergents
will
not
pose
a
health
hazard
to
humans.
Summary
Aluminosilicates
are
widely
utilized
in
the
food
industry
and
in
treating
drinking
water,
not
posing
a
human
health
hazard
under
current
conditions
of
use.
Cubic
Type
A
Zeolite,
with
a
Na:Si:Al
ratio
of
1:1:1
is
thermodynami-
cally
less
stable
than
food
grade
aluminosilicate,
with
its
corresponding
ratio
of
1:1:13
rapidly
forming
insoluble
aluminates
and
soluble
silicates
in
aqueous
suspensions
at
a
pH
<8,
hence
rarely
being
found
in
the
environment.
Type
A
Zeolite
is
essentially
non-toxic
in
acute
and
chronic
toxicity
tests
on
animals,
the
behaviour
being
representative
of
the
silicates
formed
on
hydrolysis.
No
carcinogenic
or
teratogenic
effects
were/noted
after
 
 exposure
of
experimental
animals
to
high
levels
of
Type
A
Zeolite
and
it
is
unlikely
to
produce
mutagenic
effects.
Considering
the
normal
exposure
of
man
to
natural
silicon
compounds
without
evident
health
hazards
and
the
miniscule
increase
in
silicon
levels
in
drinking
water
resulting
from
the
proposed
use
of
Type
A
Zeolite
in
detergents,
the
Task
Force
concludes
that
use
of
this
zeolite
in
detergents
is
not
anticipated
to
lead
to
adverse
human
health
effects.
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1
T for the
TASK FORCE
on the
HEALTH EFFECTS OF NON-NTA DETERGENT BUILDERS
The Science Advisory Board, formeriy the Research Advisory Board, has
previousiy investigated and made recommendations regarding the environmentai
and human heaTth impact of the use of NTA as a detergent budeer. A task
force is now working on the environmentai impact of the non-NTA detergent
budeers. The Task Force on the Heaith Effects of Non-NTA Detergent Buiiders
shoqu review the approaches used by the Task Force on HeaTth Effects of NTA
and the Task Forces on the Environmentai Effects of NTA and Non-NTA Detergent
Budeers, respectiveiy, in order to maintain some consistency in approach.
The Task Force on the Heaith Effects of Non-NTA Detergent Budeers is
charged to:
i A. (1) determine the chemicaTs which are currentTy in use as detergent
budeers;
(2) determine those chemicaTs which are TikeTy to be used in the
near future; and
(3) appraise what is known and what is unknown about the heaith
‘ effects of the substances Tisted in 1 and 2.
a B. The task force wi11 advise the Science Advisory Board regarding their
overaTT appraisaT of the impact on human health of the non-NTA
detergent builders and any specific areas which require additiona]
research.
‘
C.
These
tasks
are t
o be
compi
eted
by Ja
nuary
1, 19
79, w
ith
an in
terim
report on May 1, 1978.
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APPENDIX C
TERMS
OF
REFERENCE
FOR
THE
SCIENCE
ADVISORY
BOARD
As
used
herein,
Aresearch"
includes
development,
demonstration
and
research
actiVities,
but
does
not
include
regular
monitoring
and
surveillance
of
water
quality.
The
functions
and
responsibilities
of
the
Science
Advisory
Board
relating
to
research
activities
in Canada
and
the
United
States
concerning
the
quality
of
the
waters
of
the
Great
Lakes
System
shall
be
as follows:
(a)
to review at regular intervals these research activities in order to:
(i)
examine the adequacy and reliability of research results,
their dissemination, and the effectiveness of their
application;
(ii)
identify deficiencies in their scope, and inadequacies in
their funding and in completing schedules;
(iii) identify additional research projects that should be
undertaken;
(iv) identify specific research programs for which international
cooperation will be productive;
(b) to provide advice and consolidations of scientific opinion to the
Commission and its boards on particular problems referred to the
Advisory Board by the Commission or its boards;
(c) to facilitate both formal and informal international cooperation and
coordination of_research; and
(d) to make recommendations to the Commission.
The Science Advisory Board on its own authority may seek analyses,
assessments and recommendations from other professional, academic,
governmental or intergovernmental groups about the problems of Great Lakes
water quality research and related research activities.
The IJC shall determine the size and composition of the Science Advisory
Board. The Commission should appoint members to the Advisory Board from
appropriate Federal, State and Provincial Government agencies and from
other agencies, organizations and institutions involved in Great Lakes
research activities. In making these appointments the Commission should
consider individuals from the academic, scientific and industrial
communities and the general public. Membership should be based primarily
upon an individual's qualifications and potential contribution to the work
of the Advisory Board.
The Science Advisory Board should work at all times in close cooperation
with the Great Lakes Water Quality Board.
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